NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Women's and Children's Health (UK). Heavy Menstrual Bleeding. London: RCOG Press; 2007 Jan. (NICE Clinical Guidelines, No. 44.)

Cover of Heavy Menstrual Bleeding

Heavy Menstrual Bleeding.

Show details

References

1.
NHS Executive. Clinical Guidelines: Using Clinical Guidelines to Improve Patient Care Within the NHS. London: HMSO; 1996.
2.
National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: NICE; 2005.
3.
Oxman AD, Sackett DL, Guyatt GH. Users' guides to the medical literature. I. How to get started. The Evidence-Based Medicine Working Group. JAMA: the journal of the American Medical Association. 1993;270(17):2093–5. [PubMed: 8411577]
4.
Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA: the journal of the American Medical Association. 1993;270(21):2598–601. [PubMed: 8230645]
5.
Guyatt GH, Sackett DL, Cook DJ. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA: the journal of the American Medical Association. 1994;271(1):59–63. [PubMed: 8258890]
6.
Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA: the journal of the American Medical Association. 1994;271(9):703–7. [PubMed: 8309035]
7.
Jaeschke R, Guyatt G, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA: the journal of the American Medical Association. 1994;271(5):389–91. [PubMed: 8283589]
8.
Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine. How to Practice and Teach EBM. 2nd. Edinburgh: Churchill Livingstone; 2000.
9.
Scottish Intercollegiate Guidelines Network. SIGN 50: A Guideline Developer's Handbook. Edinburgh: SIGN; 2001. No. 50.
10.
Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford: Oxford University Press; 1997.
11.
Snowden R. The statistical analysis of menstrual bleeding patterns. Journal of Biosocial Science. 1977;9:107–20. [PubMed: 845187]
12.
Harlow SD, Campbell BC. Host factors that influence the duration of menstrual bleeding. Epidemiology. 1994;5(3):352–5. [PubMed: 8038253]
13.
Campbell H, Edstrom K, Engstrom L. World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. II. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles. Journal of Adolescent Health Care. 1986;7(4):236–44. [PubMed: 3721946]
14.
Treloar AE, Boynton RE, Behn BG, et al. Variation of the human menstrual cycle through reproductive life. International Journal of Fertility. 1967;12(1 Pt 2):77–126. [PubMed: 5419031]
15.
Matsumoto S, Nogami Y, Ohkuri S. Statistical studies on menstruation; a criticism on the definition of normal menstruation. Gunma Journal of Medical Science. 1962;11:294–318.
16.
Cazzola A. A profile of the female cycle length. Statistica. 1994;54(4):455–79. [PubMed: 12320131]
17.
Monari P, Montanari A. Length of menstrual cycles and their variability. Genus. 1998;54(3–4):95–118. [PubMed: 12290404]
18.
Kato I, Toniolo P, Koenig KL, et al. Epidemiologic correlates with menstrual cycle length in middle aged women. European Journal of Epidemiology. 1999;15(9):809–14. [PubMed: 10608360]
19.
Thomas KD, Okonofua FE, Chiboka O. A study of the menstrual patterns of adolescents in Ile-Ife, Nigeria. International Journal of Gynaecology and Obstetrics. 1990;33(1):31–4. [PubMed: 1974529]
20.
Jeyaseelan L, Antonisamy B, Rao PS. Pattern of menstrual cycle length in south Indian women: a prospective study. Social Biology. 1992;39(3–4):306–9. [PubMed: 1340049]
21.
Odujinrin OM, Ekunwe EO. Epidemiologic survey of menstrual patterns amongst adolescents in Nigeria. West African Journal of Medicine. 1991;10(3–4):244–9. [PubMed: 1790131]
22.
Munster K, Schmidt L, Helm P. Length and variation in the menstrual cycle – A cross-sectional study from a Danish county. British Journal of Obstetrics and Gynaecology. 1992;99(5):422–9. [PubMed: 1622917]
23.
Chiazze L Jr, Brayer FT, Macisco JJ Jr, et al. The length and variability of the human menstrual cycle. JAMA: the journal of the American Medical Association. 1968;203(6):377–80. [PubMed: 5694118]
24.
Harlow SD, Zeger SL. An application of longitudinal methods to the analysis of menstrual diary data. Journal of Clinical Epidemiology. 1991;44(10):1015–25. [PubMed: 1940994]
25.
Hallberg L, Hogdahl AM, Nilsson L, et al. Menstrual blood loss--a population study. Variation at different ages and attempts to define normality. Acta Obstetricia et Gynecologica Scandinavica. 1966;45(3):320–51. [PubMed: 5922481]
26.
Janssen CA, Scholten PC, Heintz AP. Reconsidering menorrhagia in gynecological practice. Is a 30-year-old definition still valid? Eur J Obstet Gynecol Reprod Biol. 1998;78(1):69–72. [PubMed: 9605452]
27.
Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. Journal of Obstetrics and Gynaecology of the British Commonwealth. 1971;78(10):933–9. [PubMed: 5111902]
28.
Payson M, Leppert P, Segars J. Epidemiology of myomas. Obstetrics and Gynecology Clinics of North America. 2006;33(1):1–11. [PMC free article: PMC4152898] [PubMed: 16504803]
29.
Cramer SF, Patel A. The frequency of uterine leiomyomas. American Journal of Clinical Pathology. 1990;94(4):435–8. [PubMed: 2220671]
30.
Cramer DW. Epidemiology of myomas. Seminars in Reproductive Endocrinology. 1992;10(4):320–4.
31.
Lurie S, Piper I, Woliovitch I, et al. Age-related prevalence of sonographicaly confirmed uterine myomas. Journal of Obstetrics and Gynaecology. 2005;25(1):42–4. [PubMed: 16147693]
32.
Kjerulff KH, Langenberg P, Seidman JD, et al. Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis. Journal of Reproductive Medicine. 1996;41(7):483–90. [PubMed: 8829060]
33.
Wegienka G, Baird DD, Hertz-Picciotto I, et al. Self-reported heavy bleeding associated with uterine leiomyomata. Obstetrics and Gynecology. 2003;101(3):431–7. [PubMed: 12636944]
34.
Sulaiman S, Khaund A, McMillan N, et al. Uterine fibroids – do size and location determine menstrual blood loss? European Journal of Obstetrics and Gynecology. 2004;115(1):85–9. [PubMed: 15223171]
35.
Vercellini P, Vendola N, Ragni G, et al. Abnormal uterine bleeding associated with iron-deficiency anemia. Etiology and role of hysteroscopy. Journal of Reproductive Medicine. 1993;38(7):502–4. [PubMed: 8410841]
36.
Fraser IS. Hysteroscopy and laparoscopy in women with menorrhagia. American Journal of Obstetrics and Gynecology. 1990;162(5):1264–9. [PubMed: 2140239]
37.
Emanuel MH, Verdel MJC, Stas H, et al. An audit of true prevalence of intra-uterine pathology: The hysteroscopical findings controlled for patient selection in 1202 patients with abnormal uterine bleeding. Gynaecological Endoscopy. 1995;4(4):237–41.
38.
Utman N, Mumtaz A. Pubertal menorrhagia: Causes and management. Medical Forum Monthly. 2002;13(6):162–4.
39.
Belsey EM, Pinol AP. Menstrual bleeding patterns in untreated women. Task Force on Long-Acting Systemic Agents for Fertility Regulation. Contraception. 1997;55(2):57–65. [PubMed: 9071513]
40.
Cote I, Jacobs P, Cumming DC. Use of health services associated with increased menstrual loss in the United States. American Journal of Obstetrics and Gynecology. 2003;188(2):343–8. [PubMed: 12592237]
41.
Shapley M, Jordan K, Croft PR. An epidemiological survey of symptoms of menstrual loss in the community. British Journal of General Practice. 2004;54(502):359–63. [PMC free article: PMC1266170] [PubMed: 15113519]
42.
Higham JM, Shaw RW. Clinical associations with objective menstrual blood volume. Eur J Obstet Gynecol Reprod Biol. 1999;82(1):73–6. [PubMed: 10192489]
43.
Janssen CA, Scholten PC, Heintz AP. Menorrhagia--a search for epidemiological risk markers. Maturitas. 1997;28(1):19–25. [PubMed: 9391991]
44.
Kritz-Silverstein D, Wingard DL, Garland FC. The association of behavior and lifestyle factors with menstrual symptoms. J Womens Health Gend Based Med. 1999;8(9):1185–93. [PubMed: 10595332]
45.
Hefnawi F, El Z, Yacout MM. Physiologic studies of menstrual blood loss. I. Range and consistency of menstrual blood loss in and iron requirements of menstruating Egyptian women. International Journal of Gynecology and Obstetrics. 1980;17(4):348–52. [PubMed: 6102053]
46.
Barer AP, Fowler MD. Blood loss during normal menstruation. American Journal of Obstetrics and Gynecology. 1936;31:979–86.
47.
Woo YL, White B, Corbally R, et al. Von Willebrand's disease: an important cause of dysfunctional uterine bleeding. Blood Coagulation and Fibrinolysis. 2002;13(2):89–93. [PubMed: 11914650]
48.
Shankar M, Lee CA, Sabin CA, et al. von Willebrand disease in women with menorrhagia: a systematic review. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(7):734–40. [PubMed: 15198765]
49.
Kadir RA, Economides DL, Sabin CA, et al. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998;351(9101):485–9. [PubMed: 9482440]
50.
Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69(2):454–9. [PubMed: 3492222]
51.
Dilley A, Drews C, Miller C, et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstetrics and Gynecology. 2001;97(4):630–6. [PubMed: 11275041]
52.
Krassas GE, Pontikides N, Kaltsas T, et al. Menstrual disturbances in thyrotoxicosis. Clinical Endocrinology. 1994;40(5):641–4. [PubMed: 8013145]
53.
Vercellini P, De Giorgi O, Aimi G, et al. Menstrual characteristics in women with and without endometriosis. Obstetrics and Gynecology. 1997;90(2):264–8. [PubMed: 9241306]
54.
Sensky TE, Liu DTY. Endometriosis: Associations with menorrhagia, infertility and oral contraceptives. International Journal of Gynecology and Obstetrics. 1979;17(6):573–6. [PubMed: 6106575]
55.
Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Human Reproduction. 1991;6(4):544–9. [PubMed: 1918305]
56.
Gordley LB, Lemasters G, Simpson SR, et al. Menstrual disorder and occupational, stress, and racial factors among military personnel. Journal of Occupational and Environmental Medicine. 2000;42(9):871–81. [PubMed: 10998762]
57.
Harlow SD, Campbell B, Lin X, et al. Ethnic differences in the length of the menstrual cycle during the postmenarcheal period. American Journal of Epidemiology. 1997;146(7):572–80. [PubMed: 9326435]
58.
Rybo G. Menstrual blood loss in relation to parity and menstrual pattern. Acta Obstetricia et Gynecologica Scandinavica. 1966;45(Suppl 7):25–45. [PubMed: 5928119]
59.
Zielhuis GA, Gijsen R, Van der Gulden JWJ. Menstrual disorders among dry-cleaning workers. Scand J Work Environ Health. 1989 Jun;15(3):238. [PubMed: 2781255]
60.
Hartz AJ, Barboriak PN, Wong A, et al. The association of obesity with infertility and related menstural abnormalities in women. Int J Obes. 1979;3(1):57–73. [PubMed: 528119]
61.
Ballinger CB, Smith AH, Hobbs PR. Factors associated with psychiatric morbidity in women--a general practice survey. Acta Psychiatrica Scandinavica. 1985;71(3):272–80. [PubMed: 3984768]
62.
Shapley M, Jordan K, Croft PR. Increased vaginal bleeding: the reasons women give for consulting primary care. Journal of Obstetrics and Gynaecology. 2003;23(1):48–50. [PubMed: 12623484]
63.
Shapley M, Jordan K, Croft PR. Why women consult with increased vaginal bleeding: a case–control study. British Journal of General Practice. 2002;52(475):108–13. [PMC free article: PMC1314217] [PubMed: 11885820]
64.
Shapley M, Croft PR, McCarney R, et al. Does psychological status predict the presentation in primary care of women with a menstrual disturbance? British Journal of General Practice. 2000;50(455):491–2. [PMC free article: PMC1313733] [PubMed: 10962793]
65.
Gath D, Osborn M, Bungay G, et al. Psychiatric disorder and gynaecological symptoms in middle aged women: a community survey. British Medical Journal Clinical Research Ed. 1987;294(6566):213–18. [PMC free article: PMC1245228] [PubMed: 3101815]
66.
Hurskainen R, Aalto AM, Teperi J, et al. Psychosocial and other characteristics of women complaining of menorrhagia, with and without actual increased menstrual blood loss. BJOG : an international journal of obstetrics and gynaecology. 2001;108(3):281–5. [PubMed: 11281469]
67.
Greenberg M. The meaning of menorrhagia: An investigation into the association between the complaint of menorrhagia and depression. Journal of Psychosomatic Research. 1983;27(3):209–14. [PubMed: 6887074]
68.
Granleese J. Personality, sexual behaviour and menstrual symptoms: their relevence to clinically presenting with menorrhagia. Person Invid Diff. 1990;11(4):379–90.
69.
Critchley HO, Warner P, Lee AJ, et al. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess. 2004 Sept;8(34):iii–iv. 1–139. [PubMed: 15361316]
70.
Vercellini P, Cortesi I, Oldani S, et al. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Human Reprod. 1997;12(8):1768–71. [PubMed: 9308809]
71.
Nagele F, O'Connor H, Davies A, et al. 2500 Outpatient diagnostic hysteroscopies. Obstetrics and Gynecology. 1996;88(1):87–92. [PubMed: 8684769]
72.
MacKenzie IZ, Bibby JG. Critical assessment of dilatation and curettage in 1029 women. Lancet. 1978;2(8089):566–8. [PubMed: 79928]
73.
Bronz L, Suter T, Rusca T. The value of transvaginal sonography with and without saline instillation in the diagnosis of uterine pathology in pre- and postmenopausal women with abnormal bleeding or suspect sonographic findings. Ultrasound in Obstetrics and Gynecology. 1997;9(1):53–8. [PubMed: 9060132]
74.
Valle RF. Hysteroscopic evaluation of patients with abnormal uterine bleeding. Surg Gynecol Obstet. 1981;153(4):521–6. [PubMed: 7280940]
75.
Alexopoulos ED, Fay TN, Simonis CD. A review of 2581 out-patient diagnostic hysteroscopies in the management of abnormal uterine bleeding. Gynaecological Endoscopy. 1999;8(2):105–10.
76.
Stovall TG, Ling FW, Morgan PL. A prospective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette. American Journal of Obstetrics and Gynecology. 1991;165(5 Part 1):1287–90. [PubMed: 1957847]
77.
Ash SJ, Farrell SA, Flowerdew G. Endometrial biopsy in DUB. Journal of Reproductive Medicine. 1996;41(12):892–6. [PubMed: 8979202]
78.
Fedele L, Bianchi S, Dorta M, et al. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertility and Sterility. 1992;58(1):94–7. [PubMed: 1624029]
79.
Vercellini P, Cortesi I, De GO, et al. Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis. Human Reproduction. 1998;13(10):2884–7. [PubMed: 9804250]
80.
Clevenger-Hoeft M, Syrop CH, Stovall DW, et al. Sonohysterography in premenopausal women with and without abnormal bleeding. Obstetrics and Gynecology. 1999;94(4):516–20. [PubMed: 10511351]
81.
Motashaw ND, Dave S. Diagnostic and therapeutic hysteroscopy in the management of abnormal uterine bleeding. Journal of Reproductive Medicine. 1990;35(6):616–20. [PubMed: 2359060]
82.
Allen DG, Correy JF, Marsden DE. Abnormal uterine bleeding and cancer of the genital tract. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1990;30(1):81–3. [PubMed: 2346457]
83.
Farquhar CM, Lethaby A, Sowter M, et al. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. American Journal of Obstetrics and Gynecology. 1999;181(3):525–9. [PubMed: 10486458]
84.
Loffer FD. Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: the value of a negative hysteroscopic view. Obstetrics and Gynecology. 1989;73(1):16–20. [PubMed: 2909040]
85.
Decloedt JF, Fenton DW. Outpatient hysteroscopy: Indications and hysteroscopic findings in pre- and postmenopausal patients. Gynaecological Endoscopy. 1999;8(3):137–41.
86.
Hammouda AA. Premenopausal and menopausal dysfunctional uterine bleeding. An analysis of 660 cases. International Surgery. 1967;47(2):194–8. [PubMed: 6034446]
87.
Office for National Statistics. Cancer Statistics Registrations. Registrations of Cancer Diagnosed in England, 2003. London: ONS; 2005.
88.
National Cancer Institute DSRPCSB. SEER 17 Incidence and Mortality, 2000–2003, with Kaposi Sarcoma and Mesothelioma. 2006.
89.
Scottish Cancer, Registry IS. Cancer of corpus uteri. Lifetime risk of developing cancer (up to the age of 90), Scotland: 1997–2001. Edinburgh: ISD Scotland; 2006.
90.
Royal College of Obstetricians and Gynaecologists. The Management of Menorrhagia in Secondary Care. London: RCOG Press; 1999. National Evidence-Based Clinical Guidelines.
91.
Schmeler KM, Soliman PT, Sun CC, et al. Endometrial cancer in young, normal-weight women. Gynecologic Oncology. 2005;99(2):388–92. [PubMed: 16051336]
92.
Soliman PT, Oh JC, Schmeler KM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstetrics and Gynecology. 2005;105(3):575–80. [PubMed: 15738027]
93.
Quinn MA, Kneale BJ, Fortune DW. Endometrial carcinoma in premenopausal women: a clinicopathological study. Gynecologic Oncology. 1985;20(3):298–306. [PubMed: 3972291]
94.
Parslov M, Lidegaard O, Klintorp S, et al. Risk factors among young women with endometrial cancer: a Danish case–control study. American Journal of Obstetrics and Gynecology. 2000;182(1 Pt 1):23–9. [PubMed: 10649152]
95.
National Institute for Health and Clinical Excellence. Referral Guidelines for Suspected Cancer. London: NICE; 2005.
96.
Clark TJ, Khan KS, Foon R, et al. Quality of life instruments in studies of menorrhagia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2002;104(2):96–104. [PubMed: 12206918]
97.
Jenkinson C, Peto V, Coulter A. Making sense of ambiguity: evaluation of internal reliability and face validity of the SF 36 questionnaire in women presenting with menorrhagia. Quality in Health Care. 1996;5(1):9–12. [PMC free article: PMC1055348] [PubMed: 10157276]
98.
Mansfield PK, Voda A, Allison G. Validating a pencil-and-paper measure of perimenopausal menstrual blood loss. Women's Health Issues. 2004;14(6):242–7. [PubMed: 15589775]
99.
Ruta DA, Garratt AM, Chadha YC, et al. Assessment of patients with menorrhagia: How valid is a structured clinical history as a measure of health status? Quality of Life Research. 1995;4(1):33–40. [PubMed: 7711689]
100.
Shaw RW, Brickley MR, Evans L, et al. Perceptions of women on the impact of menorrhagia on their health using multi-attribute utility assessment. British Journal of Obstetrics and Gynaecology. 1998;105(11):1159. [PubMed: 9853763]
101.
Abbott JA, Hawe J, Garry R. Quality of life should be considered the primary outcome for measuring success of endometrial ablation. Journal of the American Association of Gynecologic Laparoscopists. 2003;10(4):491–5. [PubMed: 14738636]
102.
Cooper KG, Bain C, Parkin DE. Comparison of microwave endometrial ablation and transcervical resection of the endometrium for treatment of heavy menstrual loss: a randomised trial. Lancet. 1999;354(9193):1859–63. [PubMed: 10584722]
103.
Hawe J, Abbott J, Hunter D, et al. A randomised controlled trial comparing the Cavaterm endometrial ablation system with the Nd:YAG laser for the treatment of dysfunctional uterine bleeding. BJOG: an International Journal of Obstetrics and Gynaecology. 2003;110(4):350–7. [PubMed: 12699795]
104.
Hurskainen R, Teperi J, Rissanen P, et al. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA: the journal of the American Medical Association. 2004;291(12):1456–63. [PubMed: 15039412]
105.
Hurskainen R, Teperi J, Rissanen P, et al. Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet. 2001;357(9252):273–7. [PubMed: 11214131]
106.
Gath D, Cooper P, Day A. Hysterectomy and psychiatric disorder: I. Levels of psychiatric morbidity before and after hysterectomy. British Journal of Psychiatry. 1982;140:335–42. [PubMed: 7093609]
107.
Smith WJ, Upton E, Shuster EJ, et al. Patient satisfaction and disease specific quality of life after uterine artery embolization. American Journal of Obstetrics and Gynecology. 2004;190(6):1697–703. [PubMed: 15284774]
108.
Byles JE, Hanrahan PF, Schofield MJ. ‘It would be good to know you're not alone’: The health care needs of women with menstrual symptoms. Family Practice. 1997;14(3):249–54. [PubMed: 9201501]
109.
Chapple A. Menorrhagia: women's perceptions of this condition and its treatment. Journal of Advanced Nursing. 1999;29(6):1500–6. [PubMed: 10354246]
110.
Marshall J. An exploration of women's concerns about heavy menstrual blood loss and their expectations regarding treatment. Journal of Reproductive and Infant Psychology. 1998;16(4):259–76.
111.
Warner PE, Critchley HOD, Lumsden MA, et al. Menorrhagia II: Is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? American Journal of Obstetrics and Gynecology. 2004;190(5):1224–9. [PubMed: 15167822]
112.
Warner PE, Critchley HOD, Lumsden MA, et al. Menorrhagia I: Measured blood loss, clinical features, and outcome in women with heavy periods – A survey with follow-up data. American Journal of Obstetrics and Gynecology. 2004;190(5):1216–23. [PubMed: 15167821]
113.
Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the United States. Obstetrics and Gynecology. 2002;100(4):683–7. [PubMed: 12383534]
114.
Mikhail BI. Health-related concerns and experiences of employed perimenopausal women in Alexandria, Egypt. Health Care for Women International. 1985;17(2):173–86. [PubMed: 8852219]
115.
Coulter A, Peto V, Jenkinson C. Quality of life and patient satisfaction following treatment for menorrhagia. Family Practice. 1994;11(4):394–401. [PubMed: 7895967]
116.
Coulter A, Peto V, Doll H. Gynaecology: the experience of patients referred to NHS and private clinics. Health Trends. 1995;27(2):57–61. [PubMed: 10153160]
117.
Spies JB, Warren EH, Mathias SD, et al. Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. Journal of Vascular and Interventional Radiology. 1999;10(10):1293–303. [PubMed: 10584643]
118.
Cooper KG, Parkin DE, Garratt AM, et al. A randomised comparison of medical and hysteroscopic management in women consulting a gynaecologist for treatment of heavy menstrual loss. British Journal of Obstetrics and Gynaecology. 1997;104(12):1360–6. [PubMed: 9422013]
119.
Learman LA, Summitt RL Jr, Varner RE, et al. Hysterectomy versus expanded medical treatment for abnormal uterine bleeding: Clinical outcomes in the medicine or surgery trial. Obstetrics and Gynecology. 2004;103(5 I):824–33. [PubMed: 15121552]
120.
Harlow SD, Campbell OMR. Epidemiology of menstrual disorders in developing countries: A systematic review. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(1):6–16. [PubMed: 14687045]
121.
Shapley M, Redman CWE. Assessment of menstrual blood loss using a pictorial chart and endometrial sampling within the community. Journal of Obstetrics and Gynaecology. 1995;15(2):123–4.
122.
Santer M, Warner P, Wyke S. A Scottish postal survey suggested that the prevailing clinical preoccupation with heavy periods does not reflect the epidemiology of reported symptoms and problems. Journal of Clinical Epidemiology. 2005;58(11):1206–10. [PubMed: 16223665]
123.
Snowden R, Christian B. Patterns and Perceptions of Menstruation a World Health Organization International Collaborative Study. London: Croon Helm; 1983.
124.
Treloar SA, Do KA, O'Connor VM, et al. Predictors of hysterectomy: an Australian study. American Journal of Obstetrics and Gynecology. 1999;180(4):945–54. [PubMed: 10203663]
125.
O'Flynn N, Britten N. Menorrhagia in general practice--disease or illness. Social Science and Medicine. 2000;50(5):651–61. [PubMed: 10658846]
126.
Chapple A, May C, Ling M. Is objective testing for menorrhagia in general practice practical? Results from a qualitative study. European Journal of General Practice. 2001;7(1):13–17.
127.
Cheyne GA, Shepherd MM. Comparison of chemical and atomic absorption methods for estimating menstrual blood loss. Journal of Medical Laboratory Technology. 1970;27(3):350–4. [PubMed: 5476007]
128.
Shaw ST Jr, Aaronson DE, Moyer DL. Quantitation of menstrual blood loss--further evaluation of the alkaline hematin method. Contraception. 1972;5(6):497–513. [PubMed: 4650663]
129.
van Eijkeren MA, Scholten PC, Christiaens GC, et al. The alkaline hematin method for measuring menstrual blood loss – a modification and its clinical use in menorrhagia. Eur J Obstet Gynecol Reprod Biol. 1986;22(5–6):345–51. [PubMed: 3770285]
130.
Vasilenko P, Kraicer PF, Kaplan R, et al. A new and simple method of measuring menstrual blood loss. Journal of Reproductive Medicine. 1988;33(3):293–7. [PubMed: 3361521]
131.
Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstetrics and Gynecology. 1995;85(6):977–82. [PubMed: 7770270]
132.
Pendergrass PB, Scott JN, Ream LJ. A rapid, noninvasive method for evaluation of total menstrual loss. Gynecologic and Obstetric Investigation. 1984;17(4):174–8. [PubMed: 6724345]
133.
Wyatt KM, Dimmock PW, Walker TJ, et al. Determination of total menstrual blood loss. Fertility and Sterility. 2001;76(1):125–31. [PubMed: 11438330]
134.
Rees MC. Role of menstrual blood loss measurements in management of complaints of excessive menstrual bleeding. British Journal of Obstetrics and Gynaecology. 1991;98(3):327–8. [PubMed: 2021577]
135.
Gannon MJ, Day P, Hammadieh N, et al. A new method for measuring menstrual blood loss and its use in screening women before endometrial ablation. British Journal of Obstetrics and Gynaecology. 1996;103(10):1029–33. [PubMed: 8863704]
136.
Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. British Journal of Obstetrics and Gynaecology. 1990;97(8):734–9. [PubMed: 2400752]
137.
Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG: an International Journal of Obstetrics and Gynaecology. 2000;107(3):320–2. [PubMed: 10740326]
138.
Deeny M, Davis JA. Assessment of menstrual blood loss in women referred for endometrial ablation. European Journal of Obstetrics Gynecology, and Reproductive Biology. 1994;57(3):179–80. [PubMed: 7713293]
139.
Barr F, Brabin L, Agbaje O. A pictorial chart for managing common menstrual disorders in Nigerian adolescents. International Journal of Gynecology and Obstetrics. 1999;66(1):51–3. [PubMed: 10458554]
140.
Chimbira TH, Anderson AB, Turnbull A. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. British Journal of Obstetrics and Gynaecology. 1980;87(7):603–9. [PubMed: 7426516]
141.
Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. American Journal of Obstetrics and Gynecology. 1984;149(7):788–93. [PubMed: 6380294]
142.
Heath AL, Skeaff CM, Gibson RS. Validation of a questionnaire method for estimating extent of menstrual blood loss in young adult women. Journal of Trace Elements in Medicine and Biology. 1999;12(4):231–5. [PubMed: 10365376]
143.
Eldred JM, Thomas EJ. Pituitary and ovarian hormone levels in unexplained menorrhagia. Obstetrics and Gynecology. 1994;84(5):775–8. [PubMed: 7936511]
144.
Haynes PJ, Anderson ABM, Turnbull AC. Patterns of menstrual blood loss in menorrhagia. Research and Clinical Forums. 1979;1(2):73–8.
145.
James A, Matchar DB, Myers ER. Testing for von Willebrand disease in women with menorrhagia: a systematic review. Obstetrics and Gynecology. 2004;104(2):381–8. [PubMed: 15292016]
146.
Claessens EA, Cowell CA. Acute adolescent menorrhagia. American Journal of Obstetrics and Gynecology. 1981;139(3):277–80. [PubMed: 6970521]
147.
Looker AC, Dallman PR, Carroll MD, et al. Prevalence of iron deficiency in the United States. JAMA: the journal of the American Medical Association. 1997;277(12):973–6. [PubMed: 9091669]
148.
Andrade AT, Souza JP, Shaw ST Jr, et al. Menstrual blood loss and body iron stores in Brazilian women. Contraception. 1991;43(3):241–9. [PubMed: 2036795]
149.
Gao J, Zeng S, Sun BL, et al. Menstrual blood loss and hematologic indices in healthy Chinese women. Journal of Reproductive Medicine. 1987;32(11):822–6. [PubMed: 3430490]
150.
Guyatt GH, Oxman AD, Ali M, et al. Laboratory diagnosis of iron-deficiency anemia: an overview. Journal of General Internal Medicine. 1992;7(2):145–53. [PubMed: 1487761]
151.
Farquhar C, Ekeroma A, Furness S, et al. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstetricia et Gynecologica Scandinavica. 2003;82(6):493–504. [PubMed: 12780419]
152.
Dueholm M, Lundorf E, Olesen F. Imaging techniques for evaluation of the uterine cavity and endometrium in premenopausal patients before minimally invasive surgery. Obstetrical and Gynecological Survey. 2002;57(6):389–403. [PubMed: 12140373]
153.
Cepni I, Ocal P, Erkan S, et al. Comparison of transvaginal sonography, saline infusion sonography and hysteroscopy in the evaluation of uterine cavity pathologies. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2005;45:30–5. [PubMed: 15730362]
154.
De Kroon CD, de Bock GH, Dieben SW, et al. Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG: an International Journal of Obstetrics and Gynaecology. 2003;110(10):938–47. [PubMed: 14550365]
155.
Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA: the journal of the American Medical Association. 2002;288(13):1610–21. [PubMed: 12350192]
156.
Baxter AJ, Beck B, Phillips K. A randomized prospective trial of rigid and flexible hysteroscopy in an outpatient setting. Gynaecological Endoscopy. 2002;11(6):357–64.
157.
Anastasiadis PG, Koutlaki NG, Skaphida PG, et al. Endometrial polyps: Prevalence, detection, and malignant potential in women with abnormal uterine bleeding. European Journal of Gynaecological Oncology. 2000;21(2):180–3. [PubMed: 10843481]
158.
Arslan M, Erdem A, Erdem M, et al. Transvaginal color Doppler ultrasonography for prediction of pre-cancerous endometrial lesions. International Journal of Gynaecology and Obstetrics. 2003;80(3):299–306. [PubMed: 12628532]
159.
Badawy A, Ash A, Nagele F, et al. Ultrasonography, hysteroscopy or both? Journal of Obstetrics and Gynaecology. 1996;16(6):551–5.
160.
Ben-Yehuda OM, Kim YB, Leuchter RS. Does hysteroscopy improve upon the sensitivity of dilatation and curettage in the diagnosis of endometrial hyperplasia or carcinoma? Gynecologic Oncology. 1998;68(1):4–7. [PubMed: 9454651]
161.
Bernard JP, Lecuru F, Darles C, et al. Saline contrast sonohysterography as first-line investigation for women with uterine bleeding. Ultrasound in Obstetrics and Gynecology. 1997;10(2):121–5. [PubMed: 9286021]
162.
Breitkopf DM, Frederickson RA, Snyder RR. Detection of benign endometrial masses by endometrial stripe measurement in premenopausal women. Obstetrics and Gynecology. 2004;104(1):120–5. [PubMed: 15229010]
163.
Chittacharoen A, Theppisai U, Linasmita V, et al. Sonohysterography in the diagnosis of abnormal uterine bleeding. Journal of Obstetrics and Gynaecology Research. 2000;26(4):277–81. [PubMed: 11049238]
164.
De CL, Kuhn R, McGinnes D. Saline infusion sonohysterosalpingography, an underutilized technique. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1997;37(2):206–9. [PubMed: 9222469]
165.
De Vries LD, Dijkhuizen FP, Mol BW, et al. Comparison of transvaginal sonography, saline infusion sonography, and hysteroscopy in premenopausal women with abnormal uterine bleeding. Journal of Clinical Ultrasound. 2000;28(5):217–23. [PubMed: 10799999]
166.
Dijkhuizen FP, Brolmann HA, Potters AE, et al. The accuracy of transvaginal ultrasonography in the diagnosis of endometrial abnormalities. Obstetrics and Gynecology. 1996;87(3):345–9. [PubMed: 8598952]
167.
Dijkhuizen FP, De Vries LD, Mol BW, et al. Comparison of transvaginal ultrasonography and saline infusion sonography for the detection of intracavitary abnormalities in premenopausal women. Ultrasound in Obstetrics and Gynecology. 2000;15(5):372–6. [PubMed: 10976476]
168.
Dueholm M, Forman A, Jensen ML, et al. Transvaginal sonography combined with saline contrast sonohysterography in evaluating the uterine cavity in premenopausal patients with abnormal uterine bleeding. Ultrasound in Obstetrics and Gynecology. 2001;18(1):54–61. [PubMed: 11489227]
169.
Dueholm M, Jensen ML, Laursen H, et al. Can the endometrial thickness as measured by trans-vaginal sonography be used to exclude polyps or hyperplasia in pre-menopausal patients with abnormal uterine bleeding? Acta Obstetricia et Gynecologica Scandinavica. 2001;80(7):645–51. [PubMed: 11437723]
170.
Emanuel MH, Wamsteker K, Lammes FB. Is dilatation and curettage obsolete for diagnosing intrauterine disorders in premenopausal patients with persistent abnormal uterine bleeding? Acta Obstetricia et Gynecologica Scandinavica. 1997;76(1):65–8. [PubMed: 9033247]
171.
Emanuel MH, Verdel MJ, Wamsteker K, et al. A prospective comparison of transvaginal ultrasonography and diagnostic hysteroscopy in the evaluation of patients with abnormal uterine bleeding: clinical implications. American Journal of Obstetrics and Gynecology. 1995;172(2 Pt 1):547–52. [PubMed: 7856684]
172.
Fedele L, Bianchi S, Dorta M, et al. Transvaginal ultrasonography versus hysteroscopy in the diagnosis of uterine submucous myomas. Obstetrics and Gynecology. 1991;77(5):745–8. [PubMed: 2014089]
173.
Fothergill DJ, Brown VA, Hill AS. Histological sampling of the endometrium – a comparison between formal curettage and the Pipelle sampler. BJOG: An International Journal of Obstetrics and Gynaecology. 1992;99(9):779–80. [PubMed: 1308108]
174.
Fukuda M, Shimizu T, Fukuda K, et al. Transvaginal hysterosonography for differential diagnosis between submucous and intramural myoma. Gynecologic and Obstetric Investigation. 1993;35(4):236–9. [PubMed: 8330769]
175.
Garuti G, Sambruni I, Colonnelli M, et al. Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women. Journal of the American Association of Gynecologic Laparoscopists. 2001;8(2):207–13. [PubMed: 11342726]
176.
Goldstein SR, Zeltser I, Horan CK, et al. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding. American Journal of Obstetrics and Gynecology. 1997;177(1):102–8. [PubMed: 9240591]
177.
Guven MA, Bese T, Demirkiran F. Comparison of hydrosonography and transvaginal ultrasonography in the detection of intracavitary pathologies in women with abnormal uterine bleeding. International Journal of Gynecological Cancer. 2004;14(1):57–63. [PubMed: 14764030]
178.
Harmanli OH, Bevilacqua SA, Dandolu V, et al. Adenomyosis interferes with accurate ultrasonographic detection of uterine leiomyomas. Archives of Gynecology and Obstetrics. 2005;273(3):146–9. [PubMed: 16001190]
179.
Indman PD. Abnormal uterine bleeding. Accuracy of vaginal probe ultrasound in predicting abnormal hysteroscopic findings. Journal of Reproductive Medicine. 1995;40(8):545–8. [PubMed: 7473448]
180.
Kavak Z, Ceyhan N, Pekin S. Combination of vaginal ultrasonography and pipelle sampling in the diagnosis of endometrial disease. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1996;36(1):63–6. [PubMed: 8775255]
181.
Kelekci S, Kaya E, Alan M, et al. Comparison of transvaginal sonography, saline infusion sonography, and office hysteroscopy in reproductive-aged women with or without abnormal uterine bleeding. Fertility and Sterility. 2005;84(3):682–6. [PubMed: 16169403]
182.
Kent ASH, Haines P, Manners BTB, et al. Blind endometrial biopsies: Insufficient for diagnosis in women with intrauterine pathology. Gynaecological Endoscopy. 1998;7(5):273–8.
183.
Khanna A, Gupta M, Shukla RC. Saline perfusion sonography and transvaginal sonography in abnormal uterine bleeding. Ultrasound International. 2001;7(1):31–6.
184.
Koonings PP, Moyer DL, Grimes DA. A randomized clinical trial comparing Pipelle and Tis-u-trap for endometrial biopsy. Obstetrics and Gynecology. 1990;75(2):293–5. [PubMed: 2405324]
185.
Krampl E, Soby B, Istre O. How representative are Pipelle endometrial biopsies? A retrospective analysis of 324 biopsies followed by transcervical resection of the endometrium or hysterectomy. Gynaecological Endoscopy. 1997;6(5):277–81.
186.
Krampl E, Bourne T, Hurlen-Solbakken H, et al. Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding. Acta Obstetricia et Gynecologica Scandinavica. 2001;80(7):616–22. [PubMed: 11437719]
187.
Laughead MK, Stones LM. Clinical utility of saline solution infusion sonohysterography in a primary care obstetric-gynecologic practice. American Journal of Obstetrics and Gynecology. 1997;176(6):1313–16. [PubMed: 9215190]
188.
Law J. Histological sampling of the endometrium--a comparison between formal curettage and the Pipelle sampler. British Journal of Obstetrics and Gynaecology. 1993;100(5):503–4. [PubMed: 8518262]
189.
Lipscomb GH, Lopatine SM, Stovall TG, et al. A randomized comparison of the Pipelle, Accurette, and Explora endometrial sampling devices. American Journal of Obstetrics and Gynecology. 1994;170(2):591–4. [PubMed: 8116719]
190.
Litta P, Vasile C, Quintieri F, et al. Correlation between hysteroscopy and histology in abnormal uterine bleeding. Italian Journal of Gynaecology and Obstetrics. 1996;8(1):22–4.
191.
Mancini F, Regnani G, Persico N, et al. Sonohysterography in the evaluation of endometrial abnormalities. Italian Journal of Gynaecology and Obstetrics. 2002;14(3):69–72.
192.
Mathew M, Gupta R, Krolikowski A. Role of transvaginal ultrasonography and diagnostic hysteroscopy in the evaluation of patients with abnormal uterine bleeding. International Journal of Gynaecology and Obstetrics. 2000;71(3):251–3. [PubMed: 11102616]
193.
Mihm LM, Quick VA, Brumfield JA, et al. The accuracy of endometrial biopsy and saline sonohysterography in the determination of the cause of abnormal uterine bleeding. American Journal of Obstetrics and Gynecology. 2002;186(5):858–60. [PubMed: 12015495]
194.
Nagele F, Bournas N, O'Connor H, et al. Comparison of carbon dioxide and normal saline for uterine distension in outpatient hysteroscopy. Fertility and Sterility. 1996;65(2):305–9. [PubMed: 8566253]
195.
Nanda S, Chadha N, Sen J, et al. Transvaginal sonography and saline infusion sonohysterography in the evaluation of abnormal uterine bleeding. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2002;42(5):530–4. [PubMed: 12495102]
196.
Ossola MW, Bertulessi C, Iasi L, et al. Comparison of saline infusion sonography to transvaginal echography and hysteroscopy in the diagnostic evaluation of abnormal uterine bleeding. Italian Journal of Gynaecology and Obstetrics. 1999;11(4):147–52.
197.
Paschopoulos M, Lolis ED, Alamanos Y, et al. Vaginoscopic hysteroscopy and transvaginal sonography in the evaluation of patients with abnormal uterine bleeding. Journal of the American Association of Gynecologic Laparoscopists. 2001;8(4):506–10. [PubMed: 11677328]
198.
Pascual A, Graupera B, Tresserra F, et al. Color Doppler transvaginal ultrasound for detecting intrauterine disorders in patients with abnormal uterine bleeding. Gynaecologia et Perinatologia. 2005;14(4):157–60.
199.
Pasqualotto EB, Margossian H, Price LL, et al. Accuracy of preoperative diagnostic tools and outcome of hysteroscopic management of menstrual dysfunction. Journal of the American Association of Gynecologic Laparoscopists. 2000;7(2):201–9. [PubMed: 10806263]
200.
Pasrija S, Trivedi SS, Narula MK. Prospective study of saline infusion sonohysterography in evaluation of perimenopausal and postmenopausal women with abnormal uterine bleeding. Journal of Obstetrics and Gynaecology Research. 2004;30(1):27–33. [PubMed: 14718017]
201.
Pungetti D, Dimicco R, Mattucci M, et al. A comparative study between panoramic hysteroscopy and endometrial biopsy. Analysis of 150 cases. Acta Europaea Fertilitatis. 1990;21(4):201–3. [PubMed: 2085062]
202.
Reinhold C, McCarthy S, Bret PM, et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology. 1996;199(1):151–8. [PubMed: 8633139]
203.
Ryu JA, Kim B, Lee J, et al. Comparison of transvaginal ultrasonography with hysterosonography as a screening method in patients with abnormal uterine bleeding. Korean Journal of Radiology. 2004;5(1):39–46. [PMC free article: PMC2698112] [PubMed: 15064558]
204.
Saidi MH, Sadler RK, Theis VD, et al. Comparison of sonography, sonohysterography, and hysteroscopy for evaluation of abnormal uterine bleeding. Journal of Ultrasound in Medicine. 1997;16(9):587–91. [PubMed: 9321777]
205.
Salim R, Lee C, Davies A, et al. A comparative study of three-dimensional saline infusion sonohysterography and diagnostic hysteroscopy for the classification of submucous fibroids. Human Reproduction. 2005;20(1):253–7. [PubMed: 15498782]
206.
Scarpellini F, Curto C, Caracussi U, et al. Transvaginal ultrasound versus histology in endometrial hyperplasia. Clinical and Experimental Obstetrics and Gynecology. 1994;21(4):266–9. [PubMed: 7994880]
207.
Schwarzler P, Concin H, Bosch H, et al. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology. Ultrasound in Obstetrics and Gynecology. 1998;11(5):337–42. [PubMed: 9644773]
208.
Smith P, Bakos O, Heimer G, et al. Transvaginal ultrasound for identifying endometrial abnormality. Acta Obstetricia et Gynecologica Scandinavica. 1991;70(7–8):591–4. [PubMed: 1785276]
209.
Taylor S, Jones S, Dixon AM, et al. Evaluation of ultrasound in an outpatient hysteroscopy clinic: Does it alter management in premenopausal women? Gynaecological Endoscopy. 2001;10(3):173–8.
210.
Torrejon R, Fernandez-Alba JJ, Carnicer I, et al. The value of hysteroscopic exploration for abnormal uterine bleeding. Journal of the American Association of Gynecologic Laparoscopists. 1997;4(4):453–6. [PubMed: 9224579]
211.
Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of patients with excessive uterine bleeding. American Journal of Obstetrics and Gynecology. 1996;174(6):1678–82. [PubMed: 8678126]
212.
Widrich T, Bradley LD, Mitchinson AR, et al. Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. American Journal of Obstetrics and Gynecology. 1996;174(4):1327–34. [PubMed: 8623865]
213.
Wood C, Hurley VA, Leoni M. The value of vaginal ultrasound in the management of menorrhagia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1993;33(2):198–200. [PubMed: 8216126]
214.
ACOG committee. Von Willebrand's disease in gynecologic practice. Obstetrics and Gynecology. 2001;98(6):1185–6. [PubMed: 11755584]
215.
Ben-Baruch G, Seidman DS, Schiff E, et al. Outpatient endometrial sampling with the Pipelle curette. Gynecologic and Obstetric Investigation. 1994;37(4):260–2. [PubMed: 8050731]
216.
Teale GR, Dunster GD. The Pipelle endometrial suction curette: How useful is it in clinical practice? Journal of Obstetrics and Gynaecology. 1998;18(1):53–5. [PubMed: 15512004]
217.
Gimpelson RJ, Rappold HO. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. American Journal of Obstetrics and Gynecology. 1988;158(3 Pt 1):489–92. [PubMed: 3348309]
218.
Ferry J, Farnsworth A, Webster M, et al. The efficacy of the pipelle endometrial biopsy in detecting endometrial carcinoma. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1993;33(1):76–8. [PubMed: 8498946]
219.
Koss LG, Schreiber K, Oberlander SG, et al. Detection of endometrial carcinoma and hyperplasia in asymptomatic women. Obstetrics and Gynecology. 1984;64(1):1–11. [PubMed: 6738931]
220.
Tahir MM, Bigrigg MA, Browning JJ, et al. A randomised controlled trial comparing transvaginal ultrasound, outpatient hysteroscopy and endometrial biopsy with inpatient hysteroscopy and curettage. British Journal of Obstetrics and Gynaecology. 1999;106(12):1259–64. [PubMed: 10609719]
221.
Bain C, Parkin DE, Cooper KG. Is outpatient diagnostic hysteroscopy more useful than endometrial biopsy alone for the investigation of abnormal uterine bleeding in unselected premenopausal women? A randomised comparison. BJOG: an International Journal of Obstetrics and Gynaecology. 2002;109(7):805–11. [PubMed: 12135218]
222.
Dijkhuizen FP, Mol BW, Brolmann HA, et al. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer. 2000;89(8):1765–72. [PubMed: 11042572]
223.
NHS. Toolkit for Producing Patient Information. London: Department of Health; 2003. Version 2.0.
224.
Kempson E. Informing Health Consumers a Review of Consumer Health Information Needs and Services. London: College of Health; 1987.
225.
Duman M. Producing Patient Information. How to Research, Develop and Produce Effective Information Resources. 2nd. London: King's Fund; 2005.
226.
Scriven A, Tucker C. The quality and management of written information presented to women undergoing hysterectomy. Journal of Clinical Nursing. 1997;6(2):107–13. [PubMed: 9188348]
227.
Augustus CE. Beliefs and perceptions of African American women who have had hysterectomy. Journal of Transcultural Nursing. 2002;13(4):296–302. [PubMed: 12325244]
228.
Uskul AK, Ahmad F, Leyland NA, et al. Women's hysterectomy experiences and decision-making. Women and Health. 2003;38(1):53–67. [PubMed: 14535606]
229.
Webb C. Professional and lay social support for hysterectomy patients. Journal of Advanced Nursing. 1986;11(2):167–77. [PubMed: 3635546]
230.
Wade J, Pletsch P, Morgan S. Hysterectomy: what do women need and want to know? JOGNN – Journal of Obstetric, Gynecologic and Neonatal Nursing. 2000;29(1):33–42. [PubMed: 10660275]
231.
Groff JY, Lees E. Decision making, beliefs, and attitudes toward hysterectomy: A focus group study with medically underserved women in Texas. Journal of Women's Health and Gender-Based Medicine. 2000;9(Suppl 2):S39–50. [PubMed: 10714744]
232.
Skea Z, Harry V, Bhattacharya S, et al. Women's perceptions of decision-making about hysterectomy. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(2):133–42. [PubMed: 14723750]
233.
O'Connor AM, Jacobsen MJ, Stacey D. An evidence-based approach to managing women's decisional conflict. JOGNN – Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2002;31(5):570–81. [PubMed: 12353737]
234.
Williams RD. A qualitative study of women's hysterectomy experience. Journal of Women's Health and Gender-Based Medicine. 2000;9(Suppl 2):S15–25. [PubMed: 10714742]
235.
O'Connor AM, Stacey D, Rovner D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2001;(3):CD001431. [PubMed: 11686990]
236.
Kennedy AD, Sculpher MJ, Coulter A, et al. A multicentre randomised controlled trial assessing the costs and benefits of using structured information and analysis of women's preferences in the management of menorrhagia. Health Technol Assess. 2003;7(8):1–76. [PubMed: 12633525]
237.
Vuorma S, Rissanen P, Aalto AM, et al. Impact of patient information booklet on treatment decision – A randomized trial among women with heavy menstruation. Health Expectations. 2003;6(4):290–7. [PubMed: 15040791]
238.
Vuorma S, Teperi J, Aalto AM, et al. A randomized trial among women with heavy menstruation -- impact of a decision aid on treatment outcomes and costs. Health Expectations. 2004;7(4):327–37. [PubMed: 15544685]
239.
Vuorma S, Teperi J, Hurskainen R, et al. Correlates of women's preferences for treatment of heavy menstrual bleeding. Patient Education and Counseling. 2003;49(2):125–32. [PubMed: 12566206]
240.
Garrud P, Wood M, Stainsby L. Impact of risk information in a patient education leaflet. Patient Education and Counseling. 2001;43(3):301–4. [PubMed: 11384827]
241.
Ridgeway V, Mathews A. Psychological preparation for surgery: A comparison of methods. British Journal of Clinical Psychology. 1982;21(4):271–80. [PubMed: 7171880]
242.
Cheung LH, Callaghan P, Chang AM. A controlled trial of psycho-educational interventions in preparing Chinese women for elective hysterectomy. International Journal of Nursing Studies. 2003;40(2):207–16. [PubMed: 12559144]
243.
Cooper KG, Parkin DE, Garratt AM, et al. Two-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. British Journal of Obstetrics and Gynaecology. 1999;106(3):258–65. [PubMed: 10426646]
244.
Bourdrez P, Bongers MY, Mol BW. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Fertility and Sterility. 2004;82(1):160–6. [PubMed: 15237006]
245.
Sculpher MJ, Dwyer N, Browning J, et al. A survey of women's preferences regarding alternative surgical treatments for menorrhagia. Health Expectations. 1998;1(2):96–105. [PubMed: 11281864]
246.
Coulter A, Peto V, Doll H. Patients' preferences and general practitioners' decisions in the treatment of menstrual disorders. Family Practice. 1994;11(1):67–74. [PubMed: 8034155]
247.
Nevadunsky NS, Bachmann GA, Nosher J, et al. Women's decision-making determinants in choosing uterine artery embolization for symptomatic fibroids. Journal of Reproductive Medicine. 2001;46(10):870–4. [PubMed: 11725729]
248.
Entwistle VA, Skea ZC, O'Donnell MT. Decisions about treatment: Interpretations of two measures of control by women having a hysterectomy. Social Science and Medicine. 2001;53(6):721–32. [PubMed: 11511048]
249.
Lindberg CE, Nolan LB. Women's decision making regarding hysterectomy. JOGNN: Journal of Obstetric, Gynecologic, and Neonatal Nursing. 2001;30(6):607–16. [PubMed: 11724196]
250.
Wu S, Chao YY, Yang C, et al. Decision-making tree for women considering hysterectomy. Journal of Advanced Nursing. 2005;51(4):361–8. [PubMed: 16086805]
251.
Longo MF, Cohen DR, Hood K, et al. Involving patients in primary care consultations: assessing preferences using discrete choice experiments. British Journal of General Practice. 2006;56(522):35–42. [PMC free article: PMC1821413] [PubMed: 16438813]
252.
Entwistle V, Williams B, Skea Z, et al. Which surgical decisions should patients participate in and how? Reflections on women's recollections of discussions about variants of hysterectomy. Social Science and Medicine. 2006;62(2):499–509. [PubMed: 16033702]
253.
Fry A, Rush R, Busby-Earle C, et al. Deciding about prophylactic oophorectomy: What is important to women at increased risk of ovarian cancer? Preventive Medicine: An International Journal Devoted to Practice and Theory. 2001;33(6):578–85. [PubMed: 11716653]
254.
Leung PL, Ng PS, Tam WH, et al. Preference on the treatments for menorrhagia in Hong Kong chinese women. Gynecologic and Obstetric Investigation. 2005;59(2):97–101. [PubMed: 15591803]
255.
Marsh F, Taylor L, Kremer C, et al. Delivering an effective outpatient service in gynaecology: An assessment of patient preference. Gynaecological Endoscopy. 2002;11(6):337–43.
256.
National Institute for Health and Clinical Excellence. Social Value Judgements Principles for the Development of NICE Guidance. London: NICE; 2005.
257.
Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: is the information good enough? British Medical Journal. 1999;318(7179):318–22. [PMC free article: PMC1114785] [PubMed: 9924064]
258.
Lethaby AE, Cooke I, Rees M. Progesterone/progestogen releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD002126. [PubMed: 16235297]
259.
Stewart A, Cummins C, Gold L, et al. The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. BJOG: an International Journal of Obstetrics and Gynaecology. 2001;108(1):74–86. [PubMed: 11213008]
260.
Barrington JW, Arunkalaivanan AS, Abdel-Fattah M. Comparison between the levonorgestrel intrauterine system (LNG-IUS) and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol. 2003;108(1):72–4. [PubMed: 12694974]
261.
Busfield RA, Farquhar CM, Sowter MC, et al. A randomised trial comparing the levonorgestrel intrauterine system and thermal balloon ablation for heavy menstrual bleeding. BJOG: an International Journal of Obstetrics and Gynaecology. 2006;113(3):257–63. [PubMed: 16487195]
262.
Cameron IT, Leask R, Kelly RW, et al. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins. 1987;34(1):99–110. [PubMed: 3685399]
263.
Crosignani PG, Vercellini P, Mosconi P, et al. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstetrics and Gynecology. 1997;90(2):257–63. [PubMed: 9241305]
264.
Halmesmaki K, Hurskainen R, Tiitinen A, et al. A randomized controlled trial hysterectomy of levenorgestrel-releasing intrauterine system in the treatment of menorrhagia – Effect of FSH levels and menopausal symptoms. Human Reproduction. 2004;19(2):378–82. [PubMed: 14747185]
265.
Irvine GA, Campbell-Brown MB, Lumsden MA, et al. Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. British Journal of Obstetrics and Gynaecology. 1998;105(6):592–8. [PubMed: 9647148]
266.
Istre O, Trolle B. Treatment of menorrhagia with the levonorgestrel intrauterine system versus endometrial resection. Fertility and Sterility. 2001;76(2):304–9. [PubMed: 11476777]
267.
Lahteenmaki P, Haukkamaa M, Puolakka J, et al. Open randomised study of use of levonorgestrel releasing intrauterine system as alternative to hysterectomy. British Medical Journal. 1998;316(7138):1122–6. [PMC free article: PMC28513] [PubMed: 9552948]
268.
Rauramo I, Elo I, Istre O. Long-term treatment of menorrhagia with levonorgestrel intrauterine system versus endometrial resection. Obstetrics and Gynecology. 2004;104(6):1314–21. [PubMed: 15572496]
269.
Reid PC, Virtanen-Kari S. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112(8):1121–5. [PubMed: 16045528]
270.
Soysal M, Soysal S, Ozer S. A randomized controlled trial of levonorgestrel releasing IUD and thermal balloon ablation in the treatment of menorrhagia. Zentralblatt fur Gynakologie. 2002;124(4):213–19. [PubMed: 12080483]
271.
Borgelt-Hansen L. Oral contraceptives: an update on health benefits and risks. Journal of the American Pharmaceutical Association. 2001;41(6):875–86. [PubMed: 11765113]
272.
Iyer V, Farquhar C, Jepson R. Oral contraceptive pills for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(2):CD000154. [PubMed: 10796696]
273.
Coulter A, Kelland J, Peto V, et al. Treating menorrhagia in primary care: An overview of drug trials and a survey of prescribing practice. International Journal of Technology Assessment in Health Care. 1995;11(3):456–71. [PubMed: 7591547]
274.
Fraser IS, McCarron G. Randomized trial of 2 hormonal and 2 prostaglandin-inhibiting agents in women with a complaint of menorrhagia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1991;31(1):66–70. [PubMed: 1872778]
275.
Lethaby A, Irvine G, Cameron I. Cyclical progestogens for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(2):CD001016. Update Software, Issue 4, 2004. [PubMed: 10796587]
276.
Bonduelle M, Walker JJ, Calder AA. A comparative study of danazol and norethisterone in dysfunctional uterine bleeding presenting as menorrhagia. Postgraduate Medical Journal. 1991;67(791):833–6. [PMC free article: PMC2399106] [PubMed: 1835005]
277.
Dunphy BC, Goerzen J, Greene CA, et al. A double-blind randomised study comparing danazol and medroxyprogesterone acetate in the management of menorrhagia. Journal of Obstetrics and Gynaecology. 1998;18(6):553–5. [PubMed: 15512177]
278.
Higham JM, Shaw RW. A comparative study of danazol, a regimen of decreasing doses of danazol, and norethindrone in the treatment of objectively proven unexplained menorrhagia. American Journal of Obstetrics and Gynecology. 1993;169(5):1134–9. [PubMed: 8238173]
279.
Preston JT, Cameron IT, Adams EJ, et al. Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. British Journal of Obstetrics and Gynaecology. 1995;102(5):401–6. [PubMed: 7612535]
280.
Fraser IS. Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1990;30(4):353–6. [PubMed: 2150587]
281.
Beaumont H, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev. 2002;(2):CD001017. Update Software, Issue 4, 2004. [PubMed: 12076401]
282.
Turnbull AC, Rees MC. Gestrinone in the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology. 1990;97(8):713–15. [PubMed: 2205289]
283.
Chimbira TH, Anderson AB, Naish C, et al. Reduction of menstrual blood loss by danazol in unexplained menorrhagia: lack of effect of placebo. British Journal of Obstetrics and Gynaecology. 1980;87(12):1152–8. [PubMed: 7002206]
284.
Dockeray CJ, Sheppard BL, Bonnar J. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia. British Journal of Obstetrics and Gynaecology. 1989;96(7):840–4. [PubMed: 2765430]
285.
Lamb MP. Danazol in menorrhagia: A double blind placebo controlled trial. Journal of Obstetrics and Gynaecology. 1987;7(3):212–16.
286.
National Collaborating Centre for Women's and Children's Health. Long-Acting Reversible Contraception: the Effective and Appropriate Use of Long-Acting Reversible Contraception. London: RCOG Press; 2005. [PubMed: 21656970]
287.
Task force on long-acting agents for the regulation of fertility. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception. 1983;28(1):1–20. [PubMed: 6226488]
288.
Said S, Omar K, Koetsawang S, et al. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. Contraception. 1987;35(6):591–610. [PubMed: 2959448]
289.
Canto De Cetina TE, Canto P, Ordonez LM. Effect of counseling to improve compliance in Mexican women receiving depotmedroxyprogesterone acetate. Contraception. 2001;63(3):143–6. [PubMed: 11368986]
290.
Friedman AJ, Hoffman DI, Comite F, et al. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebocontrolled, multicenter study. The Leuprolide Study Group. Obstetrics and Gynecology. 1991;77(5):720–5. [PubMed: 1901638]
291.
Takeuchi H, Kobori H, Kikuchi I, et al. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. Journal of Obstetrics and Gynaecology Research. 2000;26(5):325–31. [PubMed: 11147718]
292.
Carr BR, Marshburn PB, Weatherall PT, et al. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial. Journal of Clinical Endocrinology and Metabolism. 1993;76(5):1217–23. [PubMed: 8496313]
293.
Friedman AJ, Barbieri RL, Doubilet PM, et al. A randomized, double-blind trial of a gonadotropin-releasing hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteri. Obstetrical and Gynecological Survey. 1988;43(8):484–5. [PubMed: 2963759]
294.
Friedman AJ, Daly M, Juneau-Norcross M, et al. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin ‘add-back’ regimens for women with leiomyomata uteri. Journal of Clinical Endocrinology and Metabolism. 1993;76(6):1439–45. [PubMed: 8501148]
295.
Nakayama H, Yano T, Sagara Y, et al. Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata. Gynecological Endocrinology. 1999;13(6):382–9. [PubMed: 10685331]
296.
Palomba S, Affinito P, Tommaselli GA, et al. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertility and Sterility. 1998;70(1):111–18. [PubMed: 9660431]
297.
Palomba S, Orio F Jr, Morelli M, et al. Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. Journal of Clinical Endocrinology and Metabolism. 2002;87(10):4476–81. [PubMed: 12364422]
298.
Palomba S, Orio F Jr, Russo T, et al. Gonadotropin-releasing hormone agonist with or without raloxifene: effects on cognition, mood, and quality of life. Fertility and Sterility. 2004;82(2):480–2. [PubMed: 15302308]
299.
Schlaff WD, Zerhouni EA, Huth JA, et al. A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstetrics and Gynecology. 1989;74(6):856–62. [PubMed: 2511532]
300.
Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Reviews. 2000;(4):CD000249. Update Software 2004. [PubMed: 11034679]
301.
Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs. 2003;63(13):1417–33. [PubMed: 12825966]
302.
Nilsson L, Rybo G. Treatment of menorrhagia with an antifibrinolytic agent, tranexamic acid (AMCA) Acta Obstetricia et Gynecologica Scandinavica. 1967;46:572–80.
303.
Edlund M, Andersson K, Rybo G, et al. Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161) British Journal of Obstetrics and Gynaecology. 1995;102(11):913–17. [PubMed: 8534629]
304.
Callender ST, Warner GT, Cope E. Treatment of menorrhagia with tranexamic acid. A double-blind trial. British Medical Journal. 1970;4(729):214–16. [PMC free article: PMC1819762] [PubMed: 4919554]
305.
Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. British Medical Journal. 1996;313(7057):579–82. [PMC free article: PMC2352023] [PubMed: 8806245]
306.
Andersch B, Milsom I, Rybo G. An objective evaluation of flurbiprofen and tranexamic acid in the treatment of idiopathic menorrhagia. Acta Obstetricia et Gynecologica Scandinavica. 1988;67(7):645–8. [PubMed: 3073625]
307.
Vermylen J, Verhaegen-Declercq ML, Verstraete M, et al. A double blind study of the effect of tranexamic acid in essential menorrhagia. Thrombosis et Diathesis Haemorrhagica. 1968;20(3):583–7. [PubMed: 5710474]
308.
Lethaby A, Augood C, Duckitt K. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2002;(1):CD000400. Update Software, Issue 3, 2004. [PubMed: 11869575]
309.
Cameron IT, Haining R, Lumsden MA, et al. The effects of mefenamic acid and norethisterone on measured menstrual blood loss. Obstetrics and Gynecology. 1990;76(1):85–8. [PubMed: 2359570]
310.
Chamberlain G, Freeman R, Price F, et al. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding. British Journal of Obstetrics and Gynaecology. 1991;98(7):707–11. [PubMed: 1883797]
311.
Creatsas G, Cardamakis E, Deligeoroglou E, et al. Tenoxicam versus lynestrenol-ethinyl estradiol treatment of dysfunctional uterine bleeding cases during adolescence. Journal of Pediatric and Adolescent Gynecology. 1998;11(4):177–80. [PubMed: 9806127]
312.
Fraser IS, Pearse C, Shearman RP, et al. Efficacy of mefenamic acid in patients with a complaint of menorrhagia. Obstetrics and Gynecology. 1981;58(5):543–51. [PubMed: 7029369]
313.
Grover V, Usha R, Gupta U, et al. Management of cyclical menorrhagia with prostaglandin synthetase inhibitor. Asia-Oceania Journal of Obstetrics and Gynaecology. 1990;16(3):255–9. [PubMed: 2088249]
314.
Hall P, Maclachlan N, Thorn N, et al. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid. British Journal of Obstetrics and Gynaecology. 1987;94(6):554–8. [PubMed: 3304401]
315.
Jakubowicz DL, Wood C. The use of the prostaglandin synthetase inhibitor mefenamic acid in the treatment of menorrhagia. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1978;18(2):135–8.
316.
van Eijkeren MA, Christiaens GC, Geuze HJ, et al. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia. American Journal of Obstetrics and Gynecology. 1992;166(5):1419–28. [PubMed: 1595797]
317.
Vargyas JM, Campeau JD, Mishell DR Jr. Treatment of menorrhagia with meclofenamate sodium. American Journal of Obstetrics and Gynecology. 1987;157(4 Pt 1):944–50. [PubMed: 3314521]
318.
Ylikorkala O, Pekonen F. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia. Obstetrics and Gynecology. 1986;68(1):10–12. [PubMed: 3523328]
319.
Harrison RF, Cambell S. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia. Lancet. 1976;2(7980):283–5. [PubMed: 59855]
320.
Makarainen L, Ylikorkala O. Menstrual blood loss in dysmenorrhoea: effects of proquazone and indomethacin. British Journal of Obstetrics and Gynaecology. 1983;90(6):570–2. [PubMed: 6134549]
321.
Ingemanson CA, Sikstrom B, Rybo G, et al. Double-blind, placebo-controlled evaluation of diclofenac in the management of patients with IUD-related menorrhagia. Advances in Therapy. 1991;8(6):287–92.
322.
Chimbira TH, Cope E, Anderson AB, et al. The effect of danazol on menorrhagia, coagulation mechanisms, haematological indices and body weight. British Journal of Obstetrics and Gynaecology. 1979;86(1):46–50. [PubMed: 760766]
323.
Need JA, Forbes KL, Milazzo L, et al. Danazol in the treatment of menorrhagia: The effect of a 1 month induction dose (200 mg) and 2 month's maintenance therapy (200 mg, 100 mg, 50 mg or placebo) Australian and New Zealand Journal of Obstetrics and Gynaecology. 1992;32(4):346–52. [PubMed: 1290434]
324.
Milsom I, Andersson K, Andersch B, et al. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. American Journal of Obstetrics and Gynecology. 1991;164(3):879–83. [PubMed: 1900665]
325.
Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;(2):CD003855. [PubMed: 16625593]
326.
Kuppermann M, Varner RE, Summitt RL Jr, et al. Effect of hysterectomy vs medical treatment on health-related quality of life and sexual functioning: the medicine or surgery (Ms) randomized trial. JAMA: the journal of the American Medical Association. 2004;291(12):1447–55. [PubMed: 15039411]
327.
Istre O, Kittelsen N. A randomised study comparing levonorgestrel intra-uterine system (LNG IUS) and TCRE in the treatment of menorrhagia. Gynaecological Endoscopy. 1997;6(Suppl 2):42.
328.
Johnson N, Busfield R, Sadler L, et al. The management of menorrhagia – SMART study (Satisfaction with Mirena and Ablation: a Randomised Trial) BJOG: an International Journal of Obstetrics and Gynaecology. 2001;108(7):773–4. [PubMed: 11467716]
329.
Bongers MY, Mol BWJ, Brolmann HAM. Prognostic factors for the success of thermal balloon ablation in the treatment of menorrhagia. Obstetrics and Gynecology. 2002;99(6):1060–6. [PubMed: 12052600]
330.
Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(2):CD000329. Update Software, Issue 2, 2004. [PubMed: 10796528]
331.
Aberdeen Endometrial Ablation Trials Group. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. British Journal of Obstetrics and Gynaecology. 1999;106(4):360–6. erratum appears in Br J Obstet Gynaecol 1999;106(8):876. [PubMed: 10426244]
332.
Shawki O, Hebert AS, Peters AJ. Endometrial preparation before hysteroscopic surgery for uterine bleeding: A prospective randomized multicenter evaluation. Middle East Fertility Society Journal. 2000;5(1):48–52.
333.
Zupi E, Zullo F, Marconi D, et al. Hysteroscopic endometrial resection versus laparoscopic supracervical hysterectomy for menorrhagia: a prospective randomized trial. American Journal of Obstetrics and Gynecology. 2003;188(1):7–12. [PubMed: 12548189]
334.
Garside R, Stein K, Wyatt K, et al. The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling. Health Technol Assess. 2004;8(3):iii, 1–155. [PubMed: 14754561]
335.
Lethaby A, Hickey M. Endometrial destruction techniques for heavy menstrual bleeding. Cochrane Database Syst Rev. 2005;(4):CD001501. [PubMed: 16235284]
336.
Bongers MY, Bourdrez P, Heintz APM, et al. Bipolar radio frequency endometrial ablation compared with balloon endometrial ablation in dysfunctional uterine bleeding: Impact on patients' health-related quality of life. Fertility and Sterility. 2005;83(3):724–34. [PubMed: 15749505]
337.
Abbott J, Hawe J, Hunter D, et al. A double-blind randomized trial comparing the Cavaterm and the NovaSure endometrial ablation systems for the treatment of dysfunctional uterine bleeding. Fertility and Sterility. 2003;80(1):203–8. [PubMed: 12849825]
338.
Bhattacharya S, Cameron IM, Parkin DE, et al. A pragmatic randomised comparison of transcervical resection of the endometrium with endometrial laser ablation for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology. 1997;104(5):601–7. [PubMed: 9166205]
339.
Boujida VH, Philipsen T, Pelle J, et al. Five-year follow-up of endometrial ablation: endometrial coagulation versus endometrial resection. Obstetrics and Gynecology. 2002;99(6):988–92. [PubMed: 12052587]
340.
Cooper KG, Bain C, Lawrie L, et al. A randomised comparison of microwave endometrial ablation with transcervical resection of the endometrium; follow up at a minimum of five years. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112(4):470–5. [PubMed: 15777447]
341.
Cooper J, Gimpelson R, Laberge P, et al. A randomized, multicenter trial of safety and efficacy of the novasure system in the treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 2002;9(4):418–28. [PubMed: 12386350]
342.
Cooper JM, Anderson TL, Fortin CA, et al. Microwave endometrial ablation vs. rollerball electroablation for menorrhagia: Amulticenter randomized trial. Journal of the American Association of Gynecologic Laparoscopists. 2004;11(3):394–403. [PubMed: 15559355]
343.
Corson SL, Brill AI, Brooks PG, et al. One-year results of the Vesta system for endometrial ablation. Journal of the American Association of Gynecologic Laparoscopists. 2000;7(4):489–97. [PubMed: 11044499]
344.
Corson SL. A multicenter evaluation of endometrial ablation by Hydro ThermAblator and rollerball for treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 2001;8(3):359–67. [PubMed: 11509774]
345.
Duleba AJ, Heppard MC, Soderstrom RM, et al. A randomized study comparing endometrial cryoablation and rollerball electroablation for treatment of dysfunctional uterine bleeding. Journal of the American Association of Gynecologic Laparoscopists. 2003;10(1):17–26. [PubMed: 12554989]
346.
McClure N, Mamers PM, Healy DL, et al. A quantitative assessment of endometrial electrocautery in the management of menorrhagia and a comparative report of argon laser endometrial ablation. Gynaecological Endoscopy. 1992;1(4):199–202.
347.
Perino A, Castelli A, Cucinella G, et al. A randomized comparison of endometrial laser intrauterine thermotherapy and hysteroscopic endometrial resection. Fertility and Sterility. 2004;82(3):731–4. [PubMed: 15374722]
348.
Soysal ME, Soysal SK, Vicdan K. Thermal balloon ablation in myoma-induced menorrhagia under local anesthesia. Gynecologic and Obstetric Investigation. 2001;51(2):128–33. [PubMed: 11223708]
349.
Vercellini P, Oldani S, Yaylayan L, et al. Randomized comparison of vaporizing electrode and cutting loop for endometrial ablation. Obstetrics and Gynecology. 1999;94(4):521–7. [PubMed: 10511352]
350.
Van Zon-Rabelink IA, Vleugels MP, Merkus HM, et al. Endometrial ablation by rollerball electrocoagulation compared to uterine balloon thermal ablation. Technical and safety aspects. Eur J Obstet Gynecol Reprod Biol. 2003;110(2):220–3. [PubMed: 12969588]
351.
Van Zon-Rabelink IA, Vleugels MP, Merkus HM, et al. Efficacy and satisfaction rate comparing endometrial ablation by rollerball electrocoagulation to uterine balloon thermal ablation in a randomised controlled trial. Eur J Obstet Gynecol Reprod Biol. 2004;114(1):97–103. [PubMed: 15099879]
352.
Loffer FD. Three-year comparison of thermal balloon and rollerball ablation in treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 2001;8(1):48–54. [PubMed: 11172114]
353.
Loffer FD, Grainger D. Five-year follow-up of patients participating in a randomized trial of uterine balloon therapy versus rollerball ablation for treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 2002;9(4):429–35. [PubMed: 12386351]
354.
Grainger DA, Tjaden BL, Rowland C, et al. Thermal balloon and rollerball ablation to treat menorrhagia: Two-year results of a multicenter, prospective, randomized, clinical trial. Journal of the American Association of Gynecologic Laparoscopists. 2000;7(2):175–9. [PubMed: 10806258]
355.
Meyer WR, Walsh BW, Grainger DA, et al. Thermal balloon and rollerball ablation to treat menorrhagia: a multicenter comparison. Obstetrics and Gynecology. 1998;92(1):98–103. [PubMed: 9649102]
356.
Bongers MY, Bourdrez P, Mol BWJ, et al. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(10):1095–102. [PubMed: 15383112]
357.
Goldrath MH. Evaluation of HydroThermAblator and Rollerball endometrial ablation for menorrhagia 3 years after treatment. Journal of the American Association of Gynecologic Laparoscopists. 2003;10(4):505–11. [PubMed: 14738639]
358.
Pellicano M, Guida M, Acunzo G, et al. Hysteroscopic transcervical endometrial resection versus thermal destruction for menorrhagia: A prospective randomized trial on satisfaction rate. American Journal of Obstetrics and Gynecology. 2002;187(3):545–50. [PubMed: 12237625]
359.
Vihko KK, Raitala R, Taina E. Endometrial thermoablation for treatment of menorrhagia: comparison of two methods in outpatient setting. Acta Obstetricia et Gynecologica Scandinavica. 2003;82(3):269–74. [PubMed: 12694124]
360.
Bhattacharya S, Mollison J, Pinion S, et al. A comparison of bladder and ovarian function two years following hysterectomy or endometrial ablation. British Journal of Obstetrics and Gynaecology. 1996;103(9):898–903. [PubMed: 8813310]
361.
Bongers MY, Mol BW, Dijkhuizen FP, et al. Is balloon ablation as effective as endometrial electroresection in the treatment of menorrhagia? Journal of Laparoendoscopic and Advanced Surgical Techniques – Part A. 2000;10(2):85–92. [PubMed: 10794212]
362.
Gervaise A, Fernandez H, Capella-Allouc S, et al. Thermal balloon ablation versus endometrial resection for the treatment of abnormal uterine bleeding. Human Reproduction. 1999;14(11):2743–7. [PubMed: 10548614]
363.
Mousa HA, bou El Senoun GMS, Mahmood TA. Medium-term clinical outcome of women with menorrhagia treated by rollerball endometrial ablation versus abdominal hysterectomy with conservation of at least one ovary. Acta Obstetricia et Gynecologica Scandinavica. 2001;80(5):442–6. [PubMed: 11328222]
364.
Clarke A, Judge A, Herbert A, et al. Readmission to hospital 5 years after hysterectomy or endometrial resection in a national cohort study. Quality and Safety in Health Care. 2005;14(1):41–7. [PMC free article: PMC1743974] [PubMed: 15692002]
365.
Dequesne JH, Gallinat A, Garza-Leal JG, et al. Thermoregulated radiofrequency endometrial ablation. International Journal of Fertility and Women's Medicine. 1997;42(5):311–18. [PubMed: 9406837]
366.
Donnez J, Polet R, Rabinovitz R, et al. Endometrial laser intrauterine thermotherapy: The first series of 100 patients observed for 1 year. Fertility and Sterility. 2000;74(4):791–6. [PubMed: 11020525]
367.
Dutton C, Ackerson L, Phelps-Sandall B. Outcomes after rollerball endometrial ablation for menorrhagia. Obstetrics and Gynecology. 2001;98(1):35–9. [PubMed: 11430953]
368.
El-Toukhy T, Chandakas S, Grigoriadis T, et al. Outcome of the first 220 cases of endometrial balloon ablation using Cavaterm plus. Journal of Obstetrics and Gynaecology. 2004;24(6):680–3. [PubMed: 16147611]
369.
Erian J. Endometrial ablation in the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology. 1994;101(Suppl 11):19–22. [PubMed: 8043557]
370.
Erian MM, Goh JT. Transcervical endometrial resection. Journal of the American Association of Gynecologic Laparoscopists. 1996;3(2):263–6. [PubMed: 9050637]
371.
Feitoza SS, Gebhart JB, Gostout BS, et al. Efficacy of thermal balloon ablation in patients with abnormal uterine bleeding. American Journal of Obstetrics and Gynecology. 2003;189(2):453–7. [PubMed: 14520217]
372.
Ferry J, Rankin L. Transcervical resection of the endometrium using intracervical block only. A review of 278 procedures. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1994;34(4):457–61. [PubMed: 7848240]
373.
Friberg B, Ahlgren M. Thermal balloon endometrial destruction: The outcome of treatment of 117 women followed up for a maximum period of 4 years. Gynaecological Endoscopy. 2000;9(6):389–95.
374.
Gallinat A, Cosgriff N. Endometrial ablation by electroballoon coagulation: Long-term results. Gynaecological Endoscopy. 2001;10(1):37–43.
375.
Gallinat A. NovaSure impedance controlled system for endometrial ablation: Three-year follow-up on 107 patients. American Journal of Obstetrics and Gynecology. 2004;191(5):1585–9. [PubMed: 15547528]
376.
Gandhi SV, Fear KBC, Sturdee DW. Endometrial resection: Factors affecting long-term success. Gynaecological Endoscopy. 1999;8(1):41–50.
377.
Garry R, Erian J, Grochmal SA. A multi-centre collaborative study into the treatment of menorrhagia by Nd-YAG laser ablation of the endometrium. British Journal of Obstetrics and Gynaecology. 1991;98(4):357–62. [PubMed: 2031894]
378.
Garry R, Shelley-Jones D, Mooney P, et al. Six hundred endometrial laser ablations. Obstetrics and Gynecology. 1995;85(1):24–9. [PubMed: 7800318]
379.
Lefler HT Jr. Long-term follow-up of endometrial ablation by modified loop resection. Journal of the American Association of Gynecologic Laparoscopists. 2003;10(4):517–20. [PubMed: 14738641]
380.
McPherson K, Herbert A, Judge A, et al. Psychosexual health 5 years after hysterectomy: Population-based comparison with endometrial ablation for dysfunctional uterine bleeding. Health Expectations. 2005;8(3):234–43. [PubMed: 16098153]
381.
McPherson K, Herbert A, Judge A, et al. Self-reported bladder function five years post-hysterectomy. Journal of Obstetrics and Gynaecology. 2005;25(5):469–75. [PubMed: 16183583]
382.
O'Connor H, Magos A. Endometrial resection for the treatment of menorrhagia. The New England Journal of Medicine. 1996;335(3):151–6. [PubMed: 8657212]
383.
Parkin DE. Microwave endometrial ablation (MEA): A safe technique? Complication data from a prospective series of 1400 cases. Gynaecological Endoscopy. 2000;9(6):385–8.
384.
Perez-Medina T, Haya J, San FL, et al. Factors influencing long-term outcome of loop endometrial resection. Journal of the American Association of Gynecologic Laparoscopists. 2002;9(3):272–6. [PubMed: 12101321]
385.
Pooley AS, Ewen SP, Sutton CJG. Does transcervical resection of the endometrium for menorrhagia really avoid hysterectomy? Life table analysis of a large series. Journal of the American Association of Gynecologic Laparoscopists. 1998;5(3):229–35. [PubMed: 9668142]
386.
Quenby S. Listening to the patient: endometrial resection. (Research into patients' views in Liverpool.) Br J Hospital Medicine. 1997;57(10):508–11. [PubMed: 9330001]
387.
Roushdy M, Farag O, Momtaz M, et al. The relation between uterine volume and the success of endometrial resection in menorrhagia. Middle East Fertility Society Journal. 1996;1(2):142–5.
388.
Seidman DS, Bitman G, Mashiach S, et al. The effect of increasing age on the outcome of hysteroscopic endometrial resection for management of dysfunctional uterine bleeding. Journal of the American Association of Gynecologic Laparoscopists. 2000;7(1):115–19. [PubMed: 10648750]
389.
Sharma B, Preston J, Ray C. Microwave endometrial ablation for menorrhagia: Outcome at 2 years – Experience of a district general hospital. Journal of Obstetrics and Gynaecology. 2004;24(8):916–19. [PubMed: 16147652]
390.
Steffensen AJ, Schuster M. Endometrial resection and late reoperation in the treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 1997;4(3):325–9. [PubMed: 9154781]
391.
Thijssen RF. Radiofrequency induced endometrial ablation: an update. British Journal of Obstetrics and Gynaecology. 1997;104(5):608–13. [PubMed: 9166206]
392.
Tsaltas J, Taylor N, Healey M. A 6-year review of the outcome of endometrial ablation. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1998;38(1):69–72. [PubMed: 9521395]
393.
Vilos GA, Fortin CA, Sanders B, et al. Clinical trial of the uterine thermal balloon for treatment of menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 1997;4(5):559–65. [PubMed: 9348362]
394.
Vilos GA, Vilos EC, King JH. Experience with 800 hysteroscopic endometrial ablations. Journal of the American Association of Gynecologic Laparoscopists. 1996;4(1):33–8. [PubMed: 9050709]
395.
Wright B, Gannon MJ, Greenberg M, et al. Psychiatric morbidity following endometrial ablation and its association with genuine menorrhagia. BJOG: an International Journal of Obstetrics and Gynaecology. 2003;110(4):358–63. [PubMed: 12699796]
396.
Sowter MC, Lethaby A, Singla AA. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding. Cochrane Database Syst Rev. 2002;(3):CD001124. Update Software 2004. [PubMed: 12137619]
397.
English J, Daly S, McGuinness N, et al. Medical preparation of the endometrium prior to resection: Decapeptyl SR (triptorelin) versus danazol versus placebo. Minimally Invasive Therapy and Allied Technologies: MITAT. 1998;7(3):251–6.
398.
Erian MM, Thomas IL, Buck RJ, et al. The effects of danazol after endometrial resection. Results of a randomized, placebo-controlled, double-blind study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 1998;38(2):210–14. [PubMed: 9653864]
399.
Kriplani A, Manchanda R, Nath J, et al. A randomized trial of danazol pretreatment prior to endometrial resection. Eur J Obstet Gynecol Reprod Biol. 2002;103(1):68–71. [PubMed: 12039468]
400.
Jack SA, Cooper KG, Seymour J, et al. A randomised controlled trial of microwave endometrial ablation without endometrial preparation in the outpatient setting: patient acceptability, treatment outcome and costs. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112(8):1109–16. [PubMed: 16045526]
401.
Alborzi S, Parsanezhad ME, Dehbashi S. A comparison of hysteroscopic endometrial ablation for abnormal uterine bleeding in two groups of patients with or without endometrial preparation. Middle East Fertility Society Journal. 2002;7(2):135–9.
402.
Lissak A, Fruchter O, Mashiach S, et al. Immediate versus delayed treatment of perimenopausal bleeding due to benign causes by balloon thermal ablation. Journal of the American Association of Gynecologic Laparoscopists. 1999;6(2):145–50. [PubMed: 10226122]
403.
Kriplani A, Manchanda R, Monga D, et al. Depot medroxy progesterone acetate: A poor preparatory agent for endometrial resection. Gynecologic and Obstetric Investigation. 2001;52(3):180–3. [PubMed: 11598360]
404.
Sculpher M, Thompson E, Brown J, et al. A cost effectiveness analysis of goserelin compared with danazol as endometrial thinning agents. British Journal of Obstetrics and Gynaecology. 2000;107(3):340–6. [PubMed: 10740330]
405.
National Institute for Clinical Excellence. Fluid-Filled Thermal Balloon and Microwave Endometrial Ablation Techniques for Heavy Menstrual Bleeding. London: NICE; 2004. pp. 1–25. Technology Appraisal 78.
406.
National Institute for Clinical Excellence. Free Fluid Thermal Endometrial Ablation. London: NICE; 2004.
407.
National Institute for Clinical Excellence. Impedance-Controlled Bipolar Radiofrequency Ablation for Menorrhagia. London: NICE; 2004.
408.
National Institute for Health and Clinical Excellence. Endometrial Cryotherapy for Menorrhagia. London: NICE; 2006.
409.
Haynes PJ, Hodgson H, Anderson AB, et al. Measurement of menstrual blood loss in patients complaining of menorrhagia. British Journal of Obstetrics and Gynaecology. 1977;84(10):763–8. [PubMed: 921913]
410.
Crosignani PG, Vercellini P, Apolone G, et al. Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. American Journal of Obstetrics and Gynecology. 1997;177(1):95–101. [PubMed: 9240590]
411.
Dwyer N, Hutton J, Stirrat GM. Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. British Journal of Obstetrics and Gynaecology. 1993;100(3):237–43. [PubMed: 8476829]
412.
Gannon MJ, Holt EM, Fairbank J, et al. A randomised trial comparing endometrial resection and abdominal hysterectomy for the treatment of menorrhagia. British Medical Journal. 1991;303(6814):1362–4. [PMC free article: PMC1671634] [PubMed: 1760601]
413.
Pinion SB, Parkin DE, Abramovich DR, et al. Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. British Medical Journal. 1994;309(6960):979–83. [PMC free article: PMC2541307] [PubMed: 7772106]
414.
Bain C, Cooper KG, Parkin DE. Microwave endometrial ablation versus endometrial resection: a randomized controlled trial. Obstetrics and Gynecology. 2002;99(6):983–7. [PubMed: 12052586]
415.
Hawe JA, Phillips AG, Chien PF, et al. Cavaterm thermal balloon ablation for the treatment of menorrhagia. British Journal of Obstetrics and Gynaecology. 1999;106(11):1143–8. erratum appears in BJOG 2000;107(2):295. [PubMed: 10549958]
416.
Gupta JK, Hickey M, Lumsden MA, et al. >Uterine artery embolisation for symptomatic uterine fibroids. Cochrane Database Syst Rev. 2005;(4) [PubMed: 16437515]
417.
Edwards RG, Moss JG, Murray L, et al. Randomised Study of Embolisation and Surgical Treatment for Uterine Fibroids (REST) Edinburgh: Chief Scientist Office; 2006. No. CZH/4/1.
418.
Hehenkamp WJ, Volkers NA, Donderwinkel PF, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology. 2005;193(5):1618–29. [PubMed: 16260201]
419.
Hehenkamp WJ. Pain and Return to Daily Activities after Uterine Artery Embolization and Hysterectomy in the Treatment of Symptomatic Uterine Fibroids: Results from the Randomized EMMY Trial. Cardiovascular and Interventional Radiology. 2006;29(2):179–87. [PubMed: 16447002]
420.
Pinto I, Chimeno P, Romo A, et al. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment – a prospective, randomized, and controlled clinical trial. Radiology. 2003;226(2):425–31. [PubMed: 12563136]
421.
Spies JB, Allison S, Flick P, et al. Spherical polyvinyl alcohol versus tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: results of a limited randomized comparative study. Journal of Vascular and Interventional Radiology. 2005;16(11):1431–7. see comment. [PubMed: 16319148]
422.
Spies JB, Allison S, Flick P, et al. Polyvinyl alcohol particles and tris-acryl gelatin microspheres for uterine artery embolization for leiomyomas: Results of a randomized comparative study. Journal of Vascular and Interventional Radiology. 2004;15(8):793–800. [PubMed: 15297582]
423.
Vilos GA, Vilos AG, bu-Rafea B, et al. Administration of goserelin acetate after uterine artery embolization does not change the reduction rate and volume of uterine myomas. Fertility and Sterility. 2006;85(5):1478–83. [PubMed: 16579996]
424.
Razavi MK, Hwang G, Jahed A, et al. Abdominal myomectomy versus uterine fibroid embolization in the treatment of symptomatic uterine leiomyomas. AJR. 2003;180(6):1571–5. [PubMed: 12760922]
425.
Broder MS, Goodwin S, Chen G, et al. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstetrics and Gynecology. 2002;100(5):864–8. [PubMed: 12423842]
426.
Siskin GP, Shlansky-Goldberg RD, Goodwin SC, et al. A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. Journal of Vascular and Interventional Radiology. 2006;17(8):1287–95. [PubMed: 16923975]
427.
Worthington-Kirsch R, Spies JB, Myers ER, et al. The Fibroid Registry for outcomes data (FIBROID) for uterine embolization: shortterm outcomes. Obstetrics and Gynecology. 2005;106(1):52–9. erratum appears in Obstet Gynecol 2005;106(4):869. [PubMed: 15994617]
428.
Spies JB, Myers ER, Worthington-Kirsch R, et al. The FIBROID registry: Symptom and quality-of-life status 1 year after therapy. Obstetrics and Gynecology. 2005;106(6):1309–18. [PubMed: 16319257]
429.
Goodwin SC, Bradley LD, Lipman JC, et al. Uterine artery embolization versus myomectomy: A multicenter comparative study. Fertility and Sterility. 2006;85(1):14–21. [PubMed: 16412720]
430.
Katsumori T, Nakajima K, Mihara T. Is a large fibroid a high-risk factor for uterine artery embolization? American Journal of Roentgenology. 2003;181(5):1309–14. [PubMed: 14573425]
431.
Prollius A, De VC, Loggenberg E, et al. Uterine artery embolisation for symptomatic fibroids: The effect of the large uterus on outcome. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(3):239–42. [PubMed: 14961885]
432.
Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines. Uterine fibroid embolization (UFE). Number 150, October 2004. International Journal of Gynaecology and Obstetrics. 2005;89(3):305–18. [PubMed: 16001461]
433.
Spies JB, Cooper JM, Worthington-Kirsch R, et al. Outcome of uterine embolization and hysterectomy for leiomyomas: Results of a multicenter study. American Journal of Obstetrics and Gynecology. 2004;191(1):22–31. [PubMed: 15295340]
434.
Bruno J, Sterbis K, Flick P, et al. Recovery after uterine artery embolization for leiomyomas: A detailed analysis of its duration and severity. Journal of Vascular and Interventional Radiology. 2004;15(8):801–7. [PubMed: 15297583]
435.
Huang JYJ, Kafy S, Dugas A, et al. Failure of uterine fibroid embolization. Fertility and Sterility. 2006;85(1):30–5. [PubMed: 16412722]
436.
Hutchins FL Jr, Worthington-Kirsch R, Berkowitz RP. Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri. Journal of the American Association of Gynecologic Laparoscopists. 1999;6(3):279–84. [PubMed: 10459027]
437.
Katsumori T, Kasahara T, Akazawa K. Long-term outcomes of uterine artery embolization using gelatin sponge particles alone for symptomatic fibroids. AJR. American Journal of Roentgenology. 2006;186(3):848–54. [PubMed: 16498120]
438.
Marret H, Cottier JP, Alonso AM, et al. Predictive factors for fibroids recurrence after uterine artery embolisation. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112(4):461–5. [PubMed: 15777445]
439.
McLucas B, Adler L. Uterine artery embolization as therapy for myomata. Infertility and Reproductive Medicine Clinics of North America. 2000;11(1):77–94.
440.
McLucas B, Adler L, Perrella R. Predictive factors for success in uterine fibroid embolisation. Minimally Invasive Therapy and Allied Technologies: MITAT. 1999;8(6):429–32.
441.
McLucas B, Adler L, Perrella R. Uterine fibroid embolization: Nonsurgical treatment for symptomatic fibroids. Journal of the American College of Surgeons. 2001;192(1):95–105. [PubMed: 11192931]
442.
Pelage JP, Le DO, Soyer P, et al. Fibroid-related menorrhagia: treatment with superselective embolization of the uterine arteries and midterm follow-up. Radiology. 2000;215(2):428–31. [PubMed: 10796920]
443.
Pron G, Bennett J, Common A, et al. The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertility and Sterility. 2003;79(1):120–7. [PubMed: 12524074]
444.
Pron G, Cohen M, Soucie J, et al. The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life. Fertility and Sterility. 2003;79(1):112–19. [PubMed: 12524073]
445.
Pron G, Mocarski E, Bennett J, et al. Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: The Ontario Uterine Fibroid Embolization Trial. Journal of Vascular and Interventional Radiology. 2003;14(10):1243–50. [PubMed: 14551270]
446.
Rajan DK, Beecroft JR, Clark TWI, et al. Risk of intrauterine infectious complications after uterine artery embolization. Journal of Vascular and Interventional Radiology. 2004;15(12):1415–21. [PubMed: 15590799]
447.
Ravina JH, Ciraru-Vigneron N, Aymard A, et al. Uterine artery embolisation for fibroid disease: Results of a 6 year study. Minimally Invasive Therapy and Allied Technologies: MITAT. 1999;8(6):441–7.
448.
Roth AR, Spies JB, Walsh SM, et al. Pain after uterine artery embolization for leiomyomata: Can its severity be predicted and does severity predict outcome? Journal of Vascular and Interventional Radiology. 2000;11(8):1047–52. [PubMed: 10997469]
449.
Shan H, Huang MS, Guan SH, et al. Superselective uterine arterial embolization with pingyangmycin-lipiodol emulsion for management of symptomatic uterine leiomyoma. Chinese Medical Journal. 2004;117(1):75–8. [PubMed: 14733778]
450.
Spies JB, Ascher SA, Roth AR, et al. Uterine artery embolization for leiomyomata. Obstetrics and Gynecology. 2001;98(1):29–34. [PubMed: 11430952]
451.
Spies JB, Bruno J, Czeyda-Pommersheim F, et al. Long-term outcome of uterine artery embolization of leiomyomata. Obstetrics and Gynecology. 2005;106(5 I):933–9. [PubMed: 16260509]
452.
Spies JB, Roth AR, Jha RC, et al. Leiomyomata treated with uterine artery embolization: Factors associated with successful symptom and imaging outcome. Radiology. 2002;222(1):45–52. [PubMed: 11756703]
453.
Spies JB, Spector A, Roth AR, et al. Complications after uterine artery embolization for leiomyomas. Obstetrics and Gynecology. 2002;100(5):873–80. [PubMed: 12423844]
454.
Walker W, Green A, Sutton C. Bilateral uterine artery embolisation for myomata: Results, complications and failures. Minimally Invasive Therapy and Allied Technologies: MITAT. 1999;8(6):449–54.
455.
Walker WJ, Pelage JP. Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG: an International Journal of Obstetrics and Gynaecology. 2002;109(11):1262–72. [PubMed: 12452465]
456.
Watson GM, Walker WJ. Uterine artery embolisation for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women's views of the success of the treatment. BJOG: an International Journal of Obstetrics and Gynaecology. 2002;109(2):129–35. [PubMed: 11905428]
457.
Sawin SW, Pilevsky ND, Berlin JA, et al. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. American Journal of Obstetrics and Gynecology. 2000;183(6):1448–55. [PubMed: 11120509]
458.
Loffer FD. Improving results of hysteroscopic submucosal myomectomy for menorrhagia by concomitant endometrial ablation. Journal of Minimally Invasive Gynecology. 2005;12(3):254–60. [PubMed: 15922984]
459.
Derman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstetrics and Gynecology. 1991;77(4):591–4. [PubMed: 2002983]
460.
Liu WM, Tzeng CR, Yi-Jen C, et al. Combining the uterine depletion procedure and myomectomy may be useful for treating symptomatic fibroids. Fertility and Sterility. 2004;82(1):205–10. [PubMed: 15237013]
461.
Seracchioli R, Rossi S, Govoni F, et al. Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Human Reproduction. 2000;15(12):2663–8. [PubMed: 11098042]
462.
Stringer NH, Walker JC, Meyer PM. Comparison of 49 laparoscopic myomectomies with 49 open myomectomies. Journal of the American Association of Gynecologic Laparoscopists. 1997;4(4):457–64. [PubMed: 9224580]
463.
Cravello L, Farnarier J, de Montgolfier R, et al. Hysteroscopic resection of fibroids: Results with a 6-year follow-up period. Journal of Gynecologic Surgery. 1999;15(1):1–5.
464.
Vercellini P, Zaina B, Yaylayan L, et al. Hysteroscopic myomectomy: Long-term effects on menstrual pattern and fertility. Obstetrics and Gynecology. 1999;94(3):341–7. [PubMed: 10472856]
465.
De Blok S, Dijkman AB, Hemrika DJ. Transcervical resection of fibroids (TCRM): Results related to hysteroscopic classification. Gynaecological Endoscopy. 1995;4(4):243–6.
466.
Marziani R, Mossa B, Ebano V, et al. Transcervical hysteroscopic myomectomy: Long-term effects on abnormal uterine bleeding. Clinical and Experimental Obstetrics and Gynecology. 2005;32(1):23–6. [PubMed: 15864931]
467.
Olufowobi O, Sharif K, Papaionnou S, et al. Are the anticipated benefits of myomectomy achieved in women of reproductive age?A 5-year review of the results at a UK tertiary hospital. Journal of Obstetrics and Gynaecology. 2004;24(4):434–40. [PubMed: 15203587]
468.
Reilly RJ, Nour N. Abdominal myomectomy is associated with few surgical complications. Journal of Gynecologic Techniques. 1998;4(3):107–12.
469.
Lethaby A, Vollenhoven B, Sowter M. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev. 2001;(2):CD000547. [PubMed: 11405968]
470.
Agostini A, Ronda I, Franchi F, et al. Oxytocin during myomectomy: A randomized study. Eur J Obstet Gynecol Reprod Biol. 2005;118(2):235–8. [PubMed: 15653210]
471.
Celik H, Sapmaz E. Use of a single preoperative dose of misoprostol is efficacious for patients who undergo abdominal myomectomy. Fertility and Sterility. 2003;79(5):1207–10. [PubMed: 12738519]
472.
Corson SL, Brooks PG, Serden SP, et al. Effects of vasopressin administration during hysteroscopic surgery. Journal of Reproductive Medicine. 1994;39(6):419–23. [PubMed: 7932392]
473.
Fedele L, Vercellini P, Bianchi S, et al. Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. British Journal of Obstetrics and Gynaecology. 1990;97(5):393–6. [PubMed: 2115379]
474.
Fletcher H, Frederick J, Hardie M, et al. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstetrics and Gynecology. 1996;87(6):1014–18. [PubMed: 8649682]
475.
Frederick J, Fletcher H, Simeon D, et al. Intramyometrial vasopressin as a haemostatic agent during myomectomy. British Journal of Obstetrics and Gynaecology. 1994;101(5):435–7. [PubMed: 8018617]
476.
Ginsburg ES, Benson CB, Garfield JM, et al. The effect of operative technique and uterine size on blood loss during myomectomy: A prospective randomized study. Fertility and Sterility. 1993;60(6):956–62. [PubMed: 8243699]
477.
Jasonni VM, D'Anna R, Mancuso A, et al. Randomized double-blind study evaluating the efficacy on uterine fibroids shrinkage and on intra-operative blood loss of different length of leuprolide acetate depot treatment before myomectomy. Acta Obstetricia et Gynecologica Scandinavica. 2001;80(10):956–8. [PubMed: 11580742]
478.
Palomba S, Morelli M, Noia R, et al. Short-term administration of tibolone plus GnRH analog before laparoscopic myomectomy. Journal of the American Association of Gynecologic Laparoscopists. 2002;9(2):170–4. [PubMed: 11960042]
479.
Vercellini P, Trespidi L, Zaina B, et al. Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertility and Sterility. 2003;79(6):1390–5. [PubMed: 12798887]
480.
Zullo F, Palomba S, Corea D, et al. Bupivacaine plus epinephrine for laparoscopic myomectomy: A randomized placebo-controlled trial. Obstetrics and Gynecology. 2004;104(2):243–9. [PubMed: 15291994]
481.
Lefebvre G, Allaire C, Jeffrey J, et al. SOGC clinical guidelines. Hysterectomy. Journal of Obstetrics and Gynaecology Canada: JOGC. 2002;24(1):37–61. French. [PubMed: 12196887]
482.
Schilling J, Wyss P, Faisst K, et al. Swiss consensus guidelines for hysterectomy. Swiss Society of Gynecology and Obstetrics, Switzerland. International Journal of Gynaecology and Obstetrics. 1999;64(3):297–305. [PubMed: 10366053]
483.
Hurskainen R, Teperi J, Aalto AM, et al. Levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of essential menorrhagia: Predictors of outcome. Acta Obstetricia et Gynecologica Scandinavica. 2004;83(4):401–3. [PubMed: 15005790]
484.
Nagele F, Rubinger T, Magos A. Why do women choose endometrial ablation rather than hysterectomy? Fertility and Sterility. 1998;69(6):1063–6. [PubMed: 9627293]
485.
Mingo C, Herman CJ, Jasperse M. Women's stories: Ethnic variations in women's attitudes and experiences of menopause, hysterectomy, and hormone replacement therapy. J Womens Health Gend Based Med. 2000;9(Suppl 2):S27–38. [PubMed: 10714743]
486.
Nathorst-Boos J, Fuchs T, von Schoultz B. Consumer's attitude to hysterectomy: The experience of 678 women. Acta Obstetricia et Gynecologica Scandinavica. 1992;71(3):230–4. [PubMed: 1317649]
487.
Johnson N, Barlow D, Lethaby A, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2006;(2):CD003677. [PubMed: 16625589]
488.
Cheng YL, Jia HF, Wei CC, et al. Comparison of total laparoscopic hysterectomy and laparoscopically assisted vaginal hysterectomy. Gynecologic and Obstetric Investigation. 2002;53(4):214–19. [PubMed: 12186986]
489.
Darai E, Soriano D, Kimata P, et al. Vaginal hysterectomy for enlarged uteri, with or without laparoscopic assistance: randomized study. Obstetrics and Gynecology. 2001;97(5 Pt 1):712–16. [PubMed: 11339921]
490.
Ellstrom M, Ferraz-Nunes J, Hahlin M, et al. A randomized trial with a cost–consequence analysis after laparoscopic and abdominal hysterectomy. Obstetrics and Gynecology. 1998;91(1):30–4. [PubMed: 9464716]
491.
Ellstrom M, Olsen MF, Olsson JH, et al. Pain and pulmonary function following laparoscopic and abdominal hysterectomy: a randomized study. Acta Obstetricia et Gynecologica Scandinavica. 1998;77(9):923–8. [PubMed: 9808381]
492.
Ellstrom MA, Astrom M, Moller A, et al. A randomized trial comparing changes in psychological well-being and sexuality after laparoscopic and abdominal hysterectomy. Acta Obstetricia et Gynecologica Scandinavica. 2003;82(9):871–5. [PubMed: 12911451]
493.
Falcone T, Paraiso MF, Mascha E. Prospective randomized clinical trial of laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy. American Journal of Obstetrics and Gynecology. 1999;180(4):955–62. [PubMed: 10203664]
494.
Ferrari MM, Berlanda N, Mezzopane R, et al. Identifying the indications for laparoscopically assisted vaginal hysterectomy: a prospective, randomised comparison with abdominal hysterectomy in patients with symptomatic uterine fibroids. BJOG: an International Journal of Obstetrics and Gynaecology. 2000;107(5):620–5. [PubMed: 10826576]
495.
Garry R, Fountain J, Mason S, et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. British Medical Journal. 2004;328(7432):129–33. erratum appears in BMJ 2004;328(7438):494. [PMC free article: PMC314503] [PubMed: 14711749]
496.
Harkki-Siren P, Sjoberg J, Toivonen J, et al. Clinical outcome and tissue trauma after laparoscopic and abdominal hysterectomy: a randomized controlled study. Acta Obstetricia et Gynecologica Scandinavica. 2000;79(10):866–71. [PubMed: 11304971]
497.
Hwang JL, Seow KM, Tsai YL, et al. Comparative study of vaginal, laparoscopically assisted vaginal and abdominal hysterectomies for uterine myoma larger than 6 cm in diameter or uterus weighing at least 450 g: A prospective randomized study. Acta Obstetricia et Gynecologica Scandinavica. 2002;81(12):1132–8. [PubMed: 12519109]
498.
Langebrekke A, Eraker R, Nesheim BI, et al. Abdominal hysterectomy should not be considered as a primary method for uterine removal. A prospective randomised study of 100 patients referred to hysterectomy. Acta Obstetricia et Gynecologica Scandinavica. 1996;75(4):404–7. [PubMed: 8638465]
499.
Learman LA, Summitt RL Jr, Varner RE, et al. A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstetrics and Gynecology. 2003;102(3):453–62. [PubMed: 12962924]
500.
Lumsden MA, Twaddle S, Hawthorn R, et al. A randomised comparison and economic evaluation of laparoscopic-assisted hysterectomy and abdominal hysterectomy. BJOG: an International Journal of Obstetrics and Gynaecology. 2000;107(11):1386–91. [PubMed: 11117767]
501.
Marana R, Busacca M, Zupi E, et al. Laparoscopically assisted vaginal hysterectomy versus total abdominal hysterectomy: a prospective, randomized, multicenter study. American Journal of Obstetrics and Gynecology. 1999;180(2 Pt 1):270–5. [PubMed: 9988786]
502.
Miskry T, Magos A. Randomized, prospective, double-blind comparison of abdominal and vaginal hysterectomy in women without uterovaginal prolapse. Acta Obstetricia et Gynecologica Scandinavica. 2003;82(4):351–8. [PubMed: 12716320]
503.
Olsson JH, Ellstrom M, Hahlin M. A randomised prospective trial comparing laparoscopic and abdominal hysterectomy. British Journal of Obstetrics and Gynaecology. 1996;103(4):345–50. [PubMed: 8605132]
504.
Ottosen C, Lingman G, Ottosen L. Three methods for hysterectomy: a randomised, prospective study of short term outcome. BJOG: an International Journal of Obstetrics and Gynaecology. 2000;107(11):1380–5. [PubMed: 11117766]
505.
Perino A, Cucinella G, Venezia R, et al. Total laparoscopic hysterectomy versus total abdominal hysterectomy: an assessment of the learning curve in a prospective randomized study. Human Reproduction. 1999;14(12):2996–9. [PubMed: 10601085]
506.
Raju KS, Auld BJ. A randomised prospective study of laparoscopic vaginal hysterectomy versus abdominal hysterectomy each with bilateral salpingo-oophorectomy. British Journal of Obstetrics and Gynaecology. 1994;101(12):1068–71. [PubMed: 7826960]
507.
Ribeiro SC, Ribeiro RM, Santos NC, et al. A randomized study of total abdominal, vaginal and laparoscopic hysterectomy. International Journal of Gynaecology and Obstetrics. 2003;83(1):37–43. [PubMed: 14511870]
508.
Richardson RE, Bournas N, Magos AL. Is laparoscopic hysterectomy a waste of time? Lancet. 1995;345(8941):36–41. [PubMed: 7799707]
509.
Schutz K, Possover M, Merker A, et al. Prospective randomized comparison of laparoscopic-assisted vaginal hysterectomy (LAVH) with abdominal hysterectomy (AH) for the treatment of the uterus weighing >200 g. Surgical Endoscopy. 2002;16(1):121–5. [PubMed: 11961621]
510.
Seracchioli R, Venturoli S, Vianello F, et al. Total laparoscopic hysterectomy compared with abdominal hysterectomy in the presence of a large uterus. Journal of the American Association of Gynecologic Laparoscopists. 2002;9(3):333–8. [PubMed: 12101331]
511.
Soriano D, Goldstein A, Lecuru F, et al. Recovery from vaginal hysterectomy compared with laparoscopy-assisted vaginal hysterectomy: a prospective, randomized, multicenter study. Acta Obstetricia et Gynecologica Scandinavica. 2001;80(4):337–41. [PubMed: 11264609]
512.
Summitt RL Jr, Stovall TG, Lipscomb GH, et al. Randomized comparison of laparoscopy-assisted vaginal hysterectomy with standard vaginal hysterectomy in an outpatient setting. Obstetrics and Gynecology. 1992;80(6):895–901. [PubMed: 1448255]
513.
Summitt RL Jr, Stovall TG, Steege JF, et al. A multicenter randomized comparison of laparoscopically assisted vaginal hysterectomy and abdominal hysterectomy in abdominal hysterectomy candidates. Obstetrics and Gynecology. 1998;92(3):321–6. [PubMed: 9721763]
514.
Choy CM, Lau WC, Tam WH, et al. A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour. BJOG: an International Journal of Obstetrics and Gynaecology. 2002;109(2):173–7. [PubMed: 11905429]
515.
Yuen PM, Mak TW, Yim SF, et al. Metabolic and inflammatory responses after laparoscopic and abdominal hysterectomy. American Journal of Obstetrics and Gynecology. 1998;179(1):1–5. [PubMed: 9704757]
516.
Aka N, Kose G, Gonenc I, et al. Tissue trauma after vaginal hysterectomy and colporrhaphy versus abdominal hysterectomy: A randomised controlled study. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2004;44(4):328–31. [PubMed: 15282005]
517.
Benassi L, Rossi T, Kaihura CT, et al. Abdominal or vaginal hysterectomy for enlarged uteri: a randomized clinical trial. American Journal of Obstetrics and Gynecology. 2002;187(6):1561–5. [PubMed: 12501064]
518.
Gimbel H, Zobbe V, Andersen BM, et al. Randomised controlled trial of total compared with subtotal hysterectomy with one-year follow up results. BJOG: an International Journal of Obstetrics and Gynaecology. 2003;110(12):1088–98. [PubMed: 14664880]
519.
Gimbel H, Zobbe V, Andersen BJ, et al. Lower urinary tract symptoms after total and subtotal hysterectomy: results of a randomized controlled trial. International Urogynecology Journal. 2005;16(4):257–62. [PubMed: 16220584]
520.
Thakar R, Ayers S, Clarkson P, et al. Outcomes after total versus subtotal abdominal hysterectomy. New England Journal of Medicine. 2002;347(17):1318–25. [PubMed: 12397189]
521.
Kuppermann M, Summitt RL Jr, Varner RE, et al. Sexual functioning after total compared with supracervical hysterectomy: a randomized trial. Obstetrics and Gynecology. 2005;105(6):1309–18. [PubMed: 15932822]
522.
McPherson K, Metcalfe MA, Herbert A, et al. Severe complications of hysterectomy: The VALUE study. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(7):688–94. [PubMed: 15198759]
523.
Maresh MJ, Metcalfe MA, McPherson K, et al. The VALUE national hysterectomy study: description of the patients and their surgery. BJOG: an International Journal of Obstetrics and Gynaecology. 2002;109(3):302–12. [PubMed: 11950186]
524.
Varol N, Healey M, Tang P, et al. Ten-year review of hysterectomy morbidity and mortality: can we change direction? Australian and New Zealand Journal of Obstetrics and Gynaecology. 2001;41(3):295–302. [PubMed: 11592544]
525.
Meikle SF, Nugent EW, Orleans M. Complications and recovery from laparoscopy-assisted vaginal hysterectomy compared with abdominal and vaginal hysterectomy. Obstetrics and Gynecology. 1997;89(2):304–11. [PubMed: 9015041]
526.
Kjerulff KH, Langenberg PW, Rhodes JC, et al. Effectiveness of hysterectomy. Obstetrics and Gynecology. 2000;95(3):319–26. [PubMed: 10711536]
527.
Garry R, Fountain J, Brown J, et al. EVALUATE hysterectomy trial: a multicentre randomised trial comparing abdominal, vaginal and laparoscopic methods of hysterectomy. Health Technol Assess. 2004;8(26):1–154. [PubMed: 15215018]
528.
Ylikorkala O, Tiitinen A, Hulkko S, et al. Decrease in symptoms, blood loss and uterine size with nafarelin acetate before abdominal hysterectomy: a placebo-controlled, double-blind study. Human Reproduction. 1995;10(6):1470–4. [PubMed: 7593517]
529.
Weeks AD, Duffy SR, Walker JJ. A double-blind randomised trial of leuprorelin acetate prior to hysterectomy for dysfunctional uterine bleeding. BJOG: an International Journal of Obstetrics and Gynaecology. 2000;107(3):323–8. [PubMed: 10740327]
530.
Yuen PM, Rogers MS. Is laparoscopically-assisted vaginal hysterectomy associated with low operative morbidity? Australian and New Zealand Journal of Obstetrics and Gynaecology. 1996;36(1):39–43. [PubMed: 8775249]
531.
Scottish Intercollegiate Guidelines Network. Epithelial Ovarian Cancer. Edinburgh: SIGN; 2003.
532.
Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case–control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. American Journal of Epidemiology. 1992;136(10):1184–203. [PubMed: 1476141]
533.
The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. Journal of the National Cancer Institute. 1999;91(15):1310–16. [PubMed: 10433620]
534.
Aarnio M, Sankila R, Pukkala E, et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. International Journal of Cancer. 1999;81(2):214–18. [PubMed: 10188721]
535.
Rebbeck TR, Lynch HT, Neuhausen SL, et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. New England Journal of Medicine. 2002;346(21):1616–22. [PubMed: 12023993]
536.
Averette HE, Nguyen HN. The role of prophylactic oophorectomy in cancer prevention. Gynecologic Oncology. 1994;55(3 Pt 2):S38–41. [PubMed: 7835808]
537.
NIH Consensus Development Panel on Ovarian Cancer. NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA: the journal of the American Medical Association. 1995;273(6):491–7. [PubMed: 7837369]
538.
Stratton JF, Pharoah P, Smith SK, et al. A systematic review and meta-analysis of family history and risk of ovarian cancer. British Journal of Obstetrics and Gynaecology. 1998;105(5):493–9. [PubMed: 9637117]
539.
Wagner TM, Moslinger R, Langbauer G, et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group. British Journal of Cancer. 2000;82(7):1249–53. [PMC free article: PMC2374490] [PubMed: 10755396]
540.
Hallowell N. A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy. Psycho-Oncology. 2000;9(6):486–95. [PubMed: 11180583]
541.
Ballard LA, Walters MD. Transvaginal mobilization and removal of ovaries and fallopian tubes after vaginal hysterectomy. Obstetrics and Gynecology. 1996;87(1):35–9. [PubMed: 8532262]
542.
Davies A, O'Connor H, Magos AL. A prospective study to evaluate oophorectomy at the time of vaginal hysterectomy. British Journal of Obstetrics and Gynaecology. 1996;103(9):915–20. [PubMed: 8813313]
543.
Bhavnani V, Clarke A. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy. BJOG: an International Journal of Obstetrics and Gynaecology. 2003;110(2):168–74. [PubMed: 12618161]
544.
Overton C, Maresh MJ. Audit of currently available endometrial ablative techniques. Baillieres Clinical Obstetrics and Gynaecology. 1995;9(2):357–72. [PubMed: 7554618]
545.
Overton C, Hargreaves J, Maresh M. A National Survey of the Complications of Endometrial Destruction for Menstrual Disorders: the M.I.S.T.L.E.T.O.E. Study. Manchester: The Clinical Audit Unit, The Royal College of Obstetricians and Gynaecologists, St Mary's Hospital for Women and Children; 1997.
546.
Abramovich DR, Kitchener HC, Parkin DE, et al. A Scottish audit of hysteroscopic surgery for menorrhagia: Complications and follow up. British Journal of Obstetrics and Gynaecology. 1995;102(3):249–54. [PubMed: 7794852]
547.
Spies J, Niedzwiecki G, Goodwin S, et al. Training standards for physicians performing uterine artery embolization for leiomyomata: consensus statement developed by the Task Force on Uterine Artery Embolization and the standards division of the Society of Cardiovascular & Interventional Radiology – August 2000. Journal of Vascular and Interventional Radiology. 2001;12(1):19–21. [PubMed: 11200348]
548.
Royal College of Radiologists. Sub-Speciality Training Curricula: Interventional Radiology. www​.rcr.ac.uk/index.asp?PageID=530.
549.
Spies JB, Sacks D. Credentials for uterine artery embolization. Journal of Vascular and Interventional Radiology. 2004;15(2 Pt 1):111–13. [PubMed: 14963175]
550.
Arndt M, Bradbury RC, Golec JH. Surgeon volume and hospital resource utilization. Inquiry. 1995;32(4):407–17. [PubMed: 8567078]
551.
Altgassen C, Michels W, Schneider A. Learning laparoscopic-assisted hysterectomy. Obstetrics and Gynecology. 2004;104(2):308–13. [PubMed: 15292004]
552.
Luft HS, Hunt SS, Maerki SC. The volume–outcome relationship: practice-makes-perfect or selective-referral patterns? Health Services Research. 1987;22(2):157–82. [PMC free article: PMC1065430] [PubMed: 3112042]
553.
Roos LL Jr, Cageorge SM, Roos NP, et al. Centralization, certification, and monitoring. Readmissions and complications after surgery. Medical Care. 1986;24(11):1044–66. [PubMed: 3773578]
554.
Sculpher M. A cost–utility analysis of abdominal hysterectomy versus transcervical endometrial resection for the surgical treatment of menorrhagia. International Journal of Technology Assessment in Health Care. 1998;14(2):302–19. [PubMed: 9611905]
555.
Cooper KG, Jack SA, Parkin DE, et al. Five-year follow up of women randomised to medical management or transcervical resection of the endometrium for heavy menstrual loss: clinical and quality of life outcomes. BJOG: an International Journal of Obstetrics and Gynaecology. 2001;108(12):1222–8. [PubMed: 11843383]
556.
Dijkhuizen FPHL, Mol BWJ, Bongers MY, et al. Cost-effectiveness of transvaginal sonography and saline infused sonography in the evaluation of menorrhagia. International Journal of Gynecology and Obstetrics. 2003;83(1):45–52. [PubMed: 14511871]
557.
Nuffield Institute for Health and NHS Centre for Reviews and Dissemination. Hospital volume and health care outcomes, costs and patient access. Effective Health Care. 1996;2(8):1–16.
558.
Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Annals of Internal Medicine. 2002;137(6):511–20. [PubMed: 12230353]
559.
Khuri SF, Hussaini BE, Kumbhani DJ, et al. Does volume help predict outcome in surgical disease? Advances in Surgery. 2005;39:379–453. [PubMed: 16250562]
560.
Cameron IM, Mollison J, Pinion B, et al. A cost comparison of hysterectomy and hysteroscopic surgery for the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol. 1996;70(1):87–92. [PubMed: 9031926]
561.
Garside R, Stein K, Wyatt K, et al. A cost–utility analysis of microwave and thermal balloon endometrial ablation techniques for the treatment of heavy menstrual bleeding. BJOG: an International Journal of Obstetrics and Gynaecology. 2004;111(10):1103–14. [PubMed: 15383113]
562.
Sculpher M, Manca A, Abbott J, et al. Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: Results from a randomised trial. British Medical Journal. 2004;328(7432):134. [PMC free article: PMC314505] [PubMed: 14711748]
563.
Philipp CS, Dilley A, Miller CH, et al. Platelet functional defects in women with unexplained menorrhagia. Journal of Thrombosis and Haemostasis. 2003;1(3):477–84. [PubMed: 12871453]
564.
Miller CH, Dilley A, Richardson L, et al. Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women. American Journal of Hematology. 2001;67(2):125–9. [PubMed: 11343385]
565.
Friberg B, Orno AK, Lindgren A, et al. Bleeding disorders among young women: a population-based prevalence study. Acta Obstetricia et Gynecologica Scandinavica. 2006;85(2):200–6. [PubMed: 16532915]
566.
Philipp CS, Faiz A, Bowling N, et al. Age and the prevalence of bleeding disorders in women with menorrhagia. Obstetrics and Gynecology. 2005;105(1):61–6. [PubMed: 15625143]
567.
Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstetrics and Gynecology. 2001;98(5):806–14. [PubMed: 11704173]
568.
Bettocchi S, Ceci O, Vicino M, et al. Diagnostic inadequacy of dilatation and curettage. Fertility and Sterility. 2001;75(4):803–5. [PubMed: 11287038]
569.
Goldchmit R, Katz Z, Blickstein I, et al. The accuracy of endometrial Pipelle sampling with and without sonographic measurement of endometrial thickness. Obstetrics and Gynecology. 1993;82(5):727–30. [PubMed: 8414316]
570.
Hunter DC, McClure N. Abnormal uterine bleeding: an evaluation endometrial biopsy, vaginal ultrasound and outpatient hysteroscopy. Ulster Medical Journal. 2001;70(1):25–30. [PMC free article: PMC2449203] [PubMed: 11428321]
571.
Philipp CS, Miller CH, Faiz A, et al. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time. Haemophilia. 2005;11(5):497–503. [PubMed: 16128894]
572.
Redman CWE, McFarlane T, Cottrell D, et al. Improving communication between doctors and patients having a hysterectomy. Journal of Obstetrics and Gynaecology. 1986;6(4):275–6.
573.
West CP, Lumsden MA, Hillier H, et al. Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids. Human Reproduction. 1992;7(3):328–32. [PubMed: 1534089]
574.
Vuorma S, Rissanen P, Aalto AM, et al. Factors predicting choice of treatment for menorrhagia in gynaecology outpatient clinics. Social Science and Medicine. 2003;56(8):1653–60. [PubMed: 12639582]
575.
Phillips DR, Nathanson HG, Meltzer SM, et al. Transcervical electrosurgical resection of submucous leiomyomas for chronic menorrhagia. Journal of the American Association of Gynecologic Laparoscopists. 1995;2(2):147–53. erratum appears in J Am Assoc Gynecol Laparosc 1995;2(4):496. [PubMed: 9050549]
576.
Sapmaz E, Celik H. Comparison of the effects of the ligation of ascending branches of bilateral arteria uterina with tourniquet method on the intra-operative and post-operative hemorrhage in abdominal myomectomy cases. Eur J Obstet Gynecol Reprod Biol. 2003;111(1):74–7. [PubMed: 14557016]
577.
Taylor A, Sharma M, Tsirkas P, et al. Reducing blood loss at open myomectomy using triple tourniquets: A randomised controlled trial. BJOG: an International Journal of Obstetrics and Gynaecology. 2005;112(3):340–5. [PubMed: 15713151]
578.
Anonymous ACOG criteria set. Hysterectomy, abdominal or vaginal for abnormal uterine bleeding. Number 28, November 1997. Committee on Quality Assessment. American College of Obstetricians and Gynecologists. International Journal of Gynaecology and Obstetrics. 1998;60(3):314–15. [PubMed: 9544723]
579.
Casey MJ, Garcia-Padial J, Johnson C, et al. A critical analysis of laparoscopic assisted vaginal hysterectomies compared with vaginal hysterectomies unassisted by laparoscopy and transabdominal hysterectomies. Journal of Gynecologic Surgery. 1994;10(1):7–14. [PubMed: 10172059]
580.
Falkeborn M, Schairer C, Naessen T, et al. Risk of myocardial infarction after oophorectomy and hysterectomy. Journal of Clinical Epidemiology. 2000;53(8):832–7. [PubMed: 10942866]
581.
Harmanli OH, Gentzler CK, Byun S, et al. A comparison of abdominal and vaginal hysterectomy for the large uterus. International Journal of Gynaecology and Obstetrics. 2004;87(1):19–23. [PubMed: 15464771]
582.
Iversen L, Hannaford PC, Elliott AM, et al. Long term effects of hysterectomy on mortality: Nested cohort study. British Medical Journal. 2005;330(7506):1482–5. [PMC free article: PMC558457] [PubMed: 15930026]
583.
Kung FT, Hwang FR, Lin H, et al. Comparison of laparoscopically assisted vaginal hysterectomy and abdominal hysterectomy in taiwan. Journal of the Formosan Medical Association. 1996;95(10):769–75. [PubMed: 8961674]
584.
Martel MJ, Gilliland GB. Laparoscopically assisted vaginal hysterectomy: A review of 106 cases. Journal of Laparoendoscopic Surgery. 1995;5(6):371–5. [PubMed: 8746988]
585.
Mehra S, Bhat V, Mehra G. Laparoscopic vs. abdominal vs. vaginal hysterectomy. Gynaecological Endoscopy. 1999;8(1):29–34.
586.
Neumann G, Olesen PG, Hansen V, et al. The short-term prevalence of de novo urinary symptoms after different modes of hysterectomy. International Urogynecology Journal. 2004;15(1):14–19. [PubMed: 14752593]
587.
Seracchioli R, Venturoli S, Colombo FM, et al. GnRH agonist treatment before total laparoscopic hysterectomy for large uteri. Journal of the American Association of Gynecologic Laparoscopists. 2003;10(3):316–19. [PubMed: 14567804]
588.
Unger JB, Paul R, Caldito G. Hysterectomy for the massive leiomyomatous uterus. Obstetrics and Gynecology. 2002;100(6):1271–5. [PubMed: 12468173]
589.
Wattiez A, Soriano D, Fiaccavento A, et al. Total laparoscopic hysterectomy for very enlarged uteri. Journal of the American Association of Gynecologic Laparoscopists. 2002;9(2):125–30. [PubMed: 11960035]
590.
De Meeus JB, Magnin G. Indications of laparoscopic hysterectomy. Eur J Obstet Gynecol Reprod Biol. 1997;74(1):49–52. [PubMed: 9243202]
591.
Erian J, El-Toukhy T, Chandakas S, et al. One hundred cases of laparoscopic subtotal hysterectomy using the PK and Lap Loop systems. Journal of Minimally Invasive Gynecology. 2005;12(4):365–9. [PubMed: 16036200]
592.
Gath D, Rose N, Bond A, et al. Hysterectomy and psychiatric disorder: Are the levels of psychiatric morbidity falling? Psychological Medicine. 1995;25(2):277–83. [PubMed: 7675915]
593.
Harkki-Siren P, Sjoberg J, Makinen J, et al. Finnish national register of laparoscopic hysterectomies: a review and complications of 1165 operations. American Journal of Obstetrics and Gynecology. 1997;176(1 Pt 1):118–22. [PubMed: 9024101]
594.
Hur M, Kim JH, Moon JS, et al. Laparoscopically assisted vaginal hysterectomy. Journal of Reproductive Medicine. 1995;40(12):829–33. [PubMed: 8926611]
595.
Johns DA, Diamond MP. Laparoscopically assisted vaginal hysterectomy. Journal of Reproductive Medicine. 1994;39(6):424–8. [PubMed: 7932393]
596.
Malzoni M, Perniola G, Perniola F, et al. Optimizing the total laparoscopic hysterectomy procedure for benign uterine pathology. Journal of the American Association of Gynecologic Laparoscopists. 2004;11(2):211–18. [PubMed: 15200777]
597.
Panici PB, Zullo MA, Angioli R, et al. Minilaparotomy hysterectomy: a valid option for the treatment of benign uterine pathologies. Eur J Obstet Gynecol Reprod Biol. 2005;119(2):228–31. [PubMed: 15808385]
598.
Parkar RB, Thagana NG, Otieno D. Laparoscopic assisted vaginal hysterectomy for benign uterine pathology: is it time to change? East African Medical Journal. 2004;81(5):261–6. [PubMed: 15508342]
599.
Riza ED. Laparoscopically assisted vaginal hysterectomy: Report of 190 cases. Journal of Laparoendoscopic and Advanced Surgical Techniques. 1997;7(1):13–18. [PubMed: 9453860]
600.
Schofield MJ, Bennett A, Redman S, et al. Self-reported long-term outcomes of hysterectomy. British Journal of Obstetrics and Gynaecology. 1991;98(11):1129–36. [PubMed: 1760425]
601.
Takamizawa S, Minakami H, Usui R, et al. Risk of complications and uterine malignancies in women undergoing hysterectomy for presumed benign leiomyomas. Gynecologic and Obstetric Investigation. 1999;48(3):193–6. [PubMed: 10545745]
602.
Toma A, Hopman WM, Gorwill RH. Hysterectomy at a Canadian tertiary care facility: Results of a one year retrospective review. BMC Women's Health. 2004;4(10):1–7. [PMC free article: PMC535934] [PubMed: 15560842]
603.
Walker WJ, Barton-Smith P. Long-term follow up of uterine artery embolisation – An effective alternative in the treatment of fibroids. BJOG: an International Journal of Obstetrics and Gynaecology. 2006;113(4):464–8. [PubMed: 16553656]
604.
Parker WH, Broder MS, Liu Z, et al. Ovarian conservation at the time of hysterectomy for benign disease. Obstetrics and Gynecology. 2005;106(2):219–26. [PubMed: 16055568]
605.
Clark D. The DISCERN Handbook – Quality Criteria for Consumer Health Information on Treatment Choices. Oxford: Radcliffe Medical Press; 1998.
606.
Reid PC. Endometrial ablation in England-coming of age? An examination of hospital episode statistics 1989/1990 to 2004/2005. Eur J Obstet Gynecol Reprod Biol. 2006. In press. [PubMed: 17045729]
Copyright © 2007, National Collaborating Centre for Women's and Children's Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

Bookshelf ID: NBK56540
PubReader format: click here to try

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to pubmed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...